Effects of HIV-1 Tat on the enteric nervous by Ngwainmbi, Joy
Virginia Commonwealth University
VCU Scholars Compass
Theses and Dissertations Graduate School
2015
Effects of HIV-1 Tat on the enteric nervous
Joy Ngwainmbi
ngwainmbijk@vcu.edu
Follow this and additional works at: http://scholarscompass.vcu.edu/etd
Part of the Neurosciences Commons, and the Pharmacology, Toxicology and Environmental
Health Commons
© The Author
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in
Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/etd/3752
  
 
 
© Joy K. Guedia, 2015 
All Rights Reserved
EFFECTS OF HIV-1 TAT ON THE ENTERIC NERVOUS SYSTEM 
A Dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University. 
 
by 
 
JOY K. GUEDIA 
Bachelor of Science, Biomedical Science 
University of Yaoundé I, Cameroon, 2008 
 
Director: HAMID I. AKBARALI 
PROFESSOR, DEPARTMENT OF PHAMACOLOGY AND TOXICOLOGY 
 
 
 
 
 
 
 
 
 
Virginia Commonwealth University 
Richmond, Virginia 
May, 2015
iii 
 
 
Acknowledgement 
Words cannot adequately express the appreciation and gratitude I feel for everyone who 
has contributed in one way, or another to make this work a success. 
First and foremost, I would like to thank my mentor, Dr. Hamid I. Akbarali for accepting 
me into his lab, training me and for everything.  He went far and beyond what was required 
of a mentor. There was never a day I thought that he did not have my best interest. He 
provided me with an excellent environment, believed in me, encouraged me and is an 
example for me to follow. Thank you very much Hamid! 
 
I would also like to thank my committee members: Dr. Dewey, Dr. Hauser, Dr. Logothetis 
and Dr. Grider for their time, ideas, and support. I really appreciate the time you invested 
in my future.  I would like to thank Dr. Dewey for all his input towards my training. Thank 
you for providing an excellent environment at the Department of Pharmacology and 
Toxicology – a place where everyone feels accepted and important. Thank you for all your 
ideas during our lab meetings. A sincere thank you goes to Dr. Hauser for his help, his 
expertise in the HIV research field and for all the resources he provided to me. 
 
Special Thanks go to Dr. Joyce Lloyd and Suzanne Barbour. They’ve been there since the 
beginning of this journey. They were the first people with whom I spoke before joining the 
PREP program at VCU and they have been there for me throughout this journey. They 
have been a source of support, encouragement and are examples for me.  
 
iv 
 
 
I am grateful to all the past and present members of the Akbarali and Dewey labs: Dr. 
Tricia Smith, Dr. Datta De, Dr. James Kang, Dr. Dwight William, Dr. Bethany David, Dr. 
Atsushi, Dr. Kensuke, Aravind, Sukhada, Ryan, Essie, Fayez, Jacy, Maciej, Kumiko, and 
Karan. Thanks guys for being a source of encouragement and being such a support. Thanks 
Krista for helping us with the mouse work and DAR. Thank you very much Dave for all 
your help.  
Special Thanks also go to Allen. We started this program together and you have been a 
very good friend. Thank you. 
Special thanks go to Dr. Sylvia Fitting who has been a very good friend and “mentor”. 
Thank you very much for all your help Sylvia. 
 
I would also like to thank the staff of the Department of Pharmacology and Toxicology: 
Sheryol, Sallie and Pat. I would also like to thank the faculty of the Pharmacology and 
Toxicology Department for the training they provided to me. Especially Dr. Bettinger for 
the seminar course.  
 
I would not have had the opportunity to even start this program if not for the help of my 
‘big sister’ Michelia Ward. She believed in me. That was my strongest driving force 
throughout this program. I knew someone believes in me and I could not give up.  
 
I would like to thank my family for their support. I would like to thank my dad for being 
such a rock. Whenever I called him, he prayed for me, encouraged me. Special thanks go 
v 
 
 
to my mom for her support. I am what I am today because of the education that my parents 
gave me. Special thanks to my sister and her husband: Commy and Silas and brothers: 
Godwin, Seth, Paul and Caleb. 
I am grateful to my family in Northern Virginia. I would like to thank the Tangwa’s, the 
Esunge’s and the Nkaimbi’s for their help and support. I am grateful to my friend Elsie. 
Sincere thanks goes to the Guedia’s:  Papa Guedia, Alex, Ingrid, Michaelle, Isaac, Yolande 
and Axelle. I would also like to thank my friends: Dr. Brice Nouthe, Maxwell and 
Sandrine. Special thanks go to my Richmond crew: Pa Paul, Ma Bri, Sorelle, Martial, 
Anita and Samantha.  
I would like to thank my awesome husband, Dr. Gilles Guedia, for his patience, support 
and unconditional love. Thank you Darling for letting me achieve my dreams. Thank you 
for being an example of hard work and discipline to me. 
Last but not least, I would like to thank God Almighty for the strength and grace He has 
given me through life. All of these have been possible because of Him. He put all these 
amazing people on my path and has guided my life. 
  
vi 
 
 
Table of Contents 
Page 
Acknowledgements ........................................................................................................................ iii 
Clarification of contribution ............................................................................................................ x 
List of Tables ................................................................................................................................. xi 
List of Figures ............................................................................................................................... xii 
List of Abbreviations ................................................................................................................... xiv 
 
Chapter  
I Background ................................................................................................................... 1 
Human immunodeficiency virus (HIV) .................................................................... 1 
Effects of HIV on the gastrointestinal (GI) tract ...................................................... 5 
Lipopolysaccharide (LPS) ........................................................................................ 8 
HIV-1 Tat ............................................................................................................... 12 
The enteric nervous system .................................................................................... 15 
Aims ........................................................................................................................ 19 
 
II Methodology ............................................................................................................... 20 
Isolation and culture of neurons from adult mouse myenteric plexus .................... 20 
Immunocytochemistry ............................................................................................ 21 
Whole-cell patch clamp .......................................................................................... 22 
In-cell western blot ................................................................................................  23 
vii 
 
 
Gastrointestinal motility studies ............................................................................. 24 
Cytokine release ..................................................................................................... 25 
RT-PCR .................................................................................................................. 25 
MyD88 knock down assay ..................................................................................... 28 
NF-κB assay ........................................................................................................... 28 
Gastrointestinal motility monitor ............................................................................ 28 
Bacterial translocation ............................................................................................ 29 
 
III Effects of HIV-1 Tat on enteric neuronal excitability ................................................ 33 
Introduction ............................................................................................................ 33 
Results .................................................................................................................... 35 
 Tat increased enteric neuronal excitability ....................................................... 35 
 Tat produced a leftward shift in the Boltzmann’s activation curve of 
sodium channels ............................................................................................... 39 
 Tat selectively modulates sodium channels ...................................................... 41 
 Tat up-regulates Nav1.7 and Nav1.8 protein levels in enteric neurons ............. 43 
 Tat up-regulates sodium current density .......................................................... 45 
 Tat up-regulates pro-inflammatory cytokines .................................................. 47 
Discussion of aim 1 ................................................................................................ 49 
 
IV To determine the interaction of Tat with other bacterial products (the case of 
LPS) on the enteric nervous system (ENS) ............................................................ 52 
viii 
 
 
Introduction ............................................................................................................ 52 
Results .................................................................................................................... 54 
 Tat sensitizes enteric neuron/glia co-cultures to LPS mediated increase in 
IL-6, TNF-α and IL-1β ..................................................................................... 54 
 Tat sensitizes enteric glia cells to LPS mediated increase in IL-6 and  
 TNF-α ............................................................................................................... 57 
 Ilea of Tat-expressing (Tat+) mice were more sensitive to LPS induced 
increase in pro-inflammatory cytokines than Tat- mice ................................... 59 
 Tat and LPS but not Tat+LPS increased Nav1.7 and Nav1.8 ............................ 61 
 Tat LPS interaction is specific and not mediated via the TLR9 receptor ......... 63 
 Tat LPS interaction is TLR4 mediated ............................................................. 65 
Discussion of aim 2 ................................................................................................ 73 
 
V To determine the effects of Tat and it’s interaction with LPS on GI motility ............ 76 
Introduction ............................................................................................................ 76 
Results .................................................................................................................... 78 
 Tat increases GI motility .................................................................................. 78 
 Tat+ mice had higher rates of bacterial translocation than Tat- mice .............. 80 
 Tat+ mice were more sensitive to LPS mediated decrease in colonic 
motility than Tat- mice ..................................................................................... 82 
Discussion of aim 3 ................................................................................................ 86 
 
ix 
 
 
VI Conclusions and perspectives ..................................................................................... 88 
References ..................................................................................................................................... 92  
x 
 
 
Clarification of contributions 
 
 
Chapter III and part of chapter V of this dissertation has been published elsewhere 
(Ngwainmbi, J., De, D. D., Smith, T. H., El-Hage, N., Fitting, S., Kang, M., Dewey WL., 
Hauser KF., Akbarali, H. I. (2014). Effects of HIV-1 Tat on enteric neuropathogenesis. 
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 
34(43), 14243-14251) 
 
Chapter IV and part of chapter V of this dissertation has been submitted for publication 
elsewhere (Ngwainmbi,J.; Brun P.; Kang M.; Dewey,W.L.; Hauser,K.F.; Akbarali,H.I. 
HIV-1 Tat sensitizes to lipopolysaccharide-induced inflammatory cytokines via TLR4 
signaling in enteric glia (in review)) 
  
Additional manuscripts that are indirectly related to this dissertation are: 
 
Fitting, S., Ngwainmbi, J., Kang, M., Khan, F. A., Stevens, D. L., Dewey, W. L., Knapp, 
P. E., Hauser, K. F. and Akbarali, H. I. (2015), Sensitization of enteric neurons to 
morphine by HIV-1 Tat protein. Neurogastroenterology & Motility. doi: 
10.1111/nmo.12514 
 
Tricia H. Smith, Joy Ngwainmbi, Atsushi Hashimoto, William L. Dewey,Hamid I. 
Akbarali Morphine dependence in single enteric neurons from the mouse colon requires 
deletion of β-arrestin2  Physiological Reports Sep 2014,2(9)DOI: 10.14814/phy2.12140 
 
Smith, T. H., Ngwainmbi, J., Grider, J. R., Dewey, W. L., Akbarali, H. I. An In-vitro 
Preparation of Isolated Enteric Neurons and Glia from the Myenteric Plexus of the Adult 
Mouse. J. Vis. Exp. (78), e50688, doi:10.3791/50688 (2013) 
  
xi 
 
 
 
List of Tables 
 
Table 1: Primers used for RT-PCR Experiments .......................................................................... 27 
Table 2.  Tat mediated increase in neuronal excitability is Tat specific and long lasting ............ 38 
Table 3. Colon length and number of pellets immediately after dissection .................................. 81 
 
xii 
 
 
List of Figures 
Figure 1: A schematic representation of the HIV-1 virion structure and gene products 
encoded by the HIV-1 genomic sequence ....................................................................................... 3 
Figure 2: Life cycle of the HIV ....................................................................................................... 4 
Figure 3:  Schematic presentation of viral and microbial translocation across epithelial 
barrier .............................................................................................................................................. 7 
Figure 4: Schematic of the basic structure of lipopolysaccharide ................................................. 10 
Figure 5.  Activation of TLR4 by LPS .......................................................................................... 11 
Figure 6. Primary structure of HIV Tat protein ............................................................................ 14 
Figure 7. Organization of the enteric nervous system (ENS) ....................................................... 18 
Figure 8. Gastrointestinal motility monitor (GIMM) .................................................................... 31 
Figure 9.  Tat increased enteric neuronal excitability ................................................................... 37 
Figure 10. Tat changes the steady state voltage dependence of activation of sodium 
channels ......................................................................................................................................... 40 
Figure 11. Tat transcriptionally modulates Nav1.7 and Nav1.8 ................................................... 42 
Figure 12. Nav1.7 and Nav1.8 are expressed on enteric neurons and are up regulated by Tat ..... 44 
Figure 13. Tat+ neurons had higher sodium current densities compared to Tat- ......................... 46 
Figure 14. Tat selectively up-regulates pro-inflammatory cytokines ........................................... 48 
Figure 15. Tat and LPS interaction in neuron- co-cultures isolated from adult mouse ileum ...... 56 
Figure 16. Tat and LPS interaction in the CRL-2690 enteric glia cell line .................................. 58 
Figure 17. Ilea of Tat-expressing (Tat+) mice were more sensitive to LPS induced increase 
in pro-inflammatory cytokines than Tat- mice ............................................................................. 60 
xiii 
 
 
Figure 18. Tat and LPS but not Tat+LPS increased Nav1.7 and Nav1.8 ....................................... 62 
Figure 19. Tat CpG interaction in the CRL-2690 enteric glia cell line ......................................... 64 
Figure 20. Tat CpG interaction in the CRL-2690 enteric glia cell line ......................................... 66 
Figure 21. NF-κB activation ......................................................................................................... 68 
Figure 22. Phase contrast image of colonic neurons ..................................................................... 70 
Figure 23. Phase contrast image of ileum neurons ....................................................................... 71 
Figure 24. Effects of Tat and LPS neuronal pathology ................................................................. 72 
Figure 25. Tat increased GI motility in Tat transgenic mice ........................................................ 79 
Figure 26. Bacterial translocation ................................................................................................. 81 
Figure 27. GI effects of Tat and LPS interaction .......................................................................... 84 
 
  
xiv 
 
 
List of Abbreviations 
AIDS: Acquired immune deficiency syndrome 
CD4: Cluster of differentiation 4 
CCR5: Chemokine receptor type 5 
CXCR4: Chemokine receptor type 4 
CTL: Cytotoxic T lymphocyte. 
cART: Combined antiretroviral therapy 
CNS: Central nervous system 
CpG: cytosine triphosphate deoxynucleotide guanine triphosphate deoxynucleotide 
phosphodiester 
DNA: Deoxyribonucleic acid 
DRG: Dorsal root ganglion 
DOX: Doxycycline 
EGCs: Enteric glia cells 
ELISA:  Enzyme-linked immunosorbent assay 
ENS: Enteric nervous system 
GFAP: Glial fibrillary acidic protein 
GI: Gastrointestinal 
HIV: Human immunodeficiency virus 
IL-6: Interleukin six 
IL-1 β: Interleukin 1 beta 
LMMP: Longitudinal muscle myenteric plexus 
xv 
 
 
LPS: Lipopolysaccharide 
mRNA: Messenger ribonucleic acid 
MLN: Mesenteric lymph node 
NF-κB: Nuclear factor kappa-light-chain-enhancer of activated B cells 
PAMP: Pathogen associated molecular pattern 
RANTES: Regulated on activation, normal T cell expressed and secreted 
RNA: Ribonucleic acid 
RT-PCR: Real time polymerase chain reaction 
SiRNA: Small interfering ribonucleic acid 
SIV: Simian immunodeficiency virus 
TLR4: Toll like receptor 4 
TLR9: Toll like receptor 9 
TRIF: TIR-domain-containing adapter-inducing interferon-β 
Th17: T helper cells producing interleukin 17 
Tat: trans-activator of transcription 
TTX: Tetrodotoxin 
TNF-α: Tumor necrosis factor alpha 
VGSC: Voltage gated sodium channels 
 
 
  
 
 
 
 
 
Abstract 
 
 
 
Effects of HIV-1 Tat on the Enteric Nervous System 
By Joy K. Guedia, BS 
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2015 
 
Major Director:  Hamid I. Akbarali, PhD 
Professor, Department of Pharmacology and Toxicology 
 
 
 
More than 1.2 million people are estimated to be currently living with the human 
immunodeficiency virus (HIV) in the United States of America. The gastrointestinal (GI) 
tract is both a major target and an important component of HIV pathogenesis. The GI 
processes that are dysregulated during HIV infection are controlled by the enteric nervous 
system (ENS). Indeed, both clinical and experimental studies have implicated the ENS in 
HIV and simian immunodeficiency virus (SIV) pathogenesis. In addition to direct viral 
effects, the HIV virus also indirectly affects the GI tract via cellular and/or viral toxins 
released by infected cells. Trans-activator of transcription (Tat) is a viral toxin that plays 
an important role in replication of the HIV virus. While, the HIV virus does not directly 
infect neurons, Tat has been shown to modulate neuronal function. HIV infection in the gut 
is accompanied by: translocation of bacteria and bacterial products from the gut lumen to 
 
 
 
peripheral blood, immune activation and inflammation. Lipopolysaccharide (LPS) is a 
major bacterial product that is used to determine the rate of bacterial translocation and to 
drive inflammation. Despite reports of enteric ganglionitis in SIV infected monkeys and 
autonomic denervation in the jejunum of HIV patients, little is known of the mechanism 
underlying enteric neuropathogenesis in HIV and the role of the ENS in HIV pathogenesis.  
In the present study, we assessed the effects of Tat on enteric neuronal excitability and 
how Tat and LPS interact in the ENS to bring about inflammation and GI motility 
problems observed in HIV patients. We show that Tat significantly increased enteric 
neuronal excitability by modulating sodium channels expressed on enteric neurons. Tat 
sensitized ENS cells to LPS-mediated increase in pro-inflammatory cytokines via a TLR4-
mediated pathway involving MyD88. Mice expressing the tat transgene (Tat+) had faster 
GI transit rates and significantly higher frequencies of diameter changes in the proximal 
ileum than controls (Tat-). Tat+ mice were also more sensitive to LPS-mediated decreases 
in colonic transit rate. This study highlights the role of viral and bacterial proteins in HIV 
pathogenesis in the gastrointestinal tract and also demonstrates a critical role of the ENS in 
HIV pathogenesis.  
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Chapter I 
Background 
 
Human immunodeficiency virus (HIV) 
HIV belongs to the retroviridae family and is the causative agent of acquired 
immunodeficiency syndrome (AIDS). There are two main types of HIV: HIV-1 and HIV-
2. Even though both cause similar clinical symptoms, HIV-1 is more common while HIV-2 
is less common, less easily transmitted and has a longer period between infection and 
disease manifestation. Generally, when the term HIV is used without specifying, people 
are referring to HIV-1 because it is the most widespread. I will simply refer to HIV-1 as 
HIV in this study.  HIV is further divided into 4 main groups: M, N, O, and P. Group M-
the major group is the most frequent comprising about 90% of all infections. Group O-the 
outlier has mostly been reported in Central and West Africa. Groups P and N are newer, 
very rare and have been reported in Cameroon (Abecasis et al., 2013; Plantier et al., 2009). 
Group M presents the most diversity. It is further divided into nine distinct clades 
(subtypes) and a number of circulating recombinant forms (CRFs). These clades include: 
A, B, C, D, F, G, H, J and K (Abecasis et al., 2013; Buonaguro, Tornesello, & Buonaguro, 
2007).  
The HIV virion is made up of a phospholipid envelope from which protrude glycolipids 
GP41 and GP120. The envelope surrounds a neucleocapside, which encapsulates 2 single 
stranded RNA. The HIV genome is composed of 9 genes encoding: 3 structural, 2 
  
2 
envelope, and 6 regulatory proteins in addition to 3 enzymes (integrase, reverse 
transcriptase, and protease) required for viral life cycle (Figure 1).  The life cycle of HIV 
involves the following stages depicted in Figure 2: viral entry, reverse transcription, 
integration, transcription, translation, budding and maturation (Figure 2).   
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Figure 1. A schematic representation of the HIV-1 virion structure and gene products 
encoded by the HIV-1 genomic sequence. 
 Adapted from Hope Thomas J., Trono D. "Structure, expression and regulation of the 
HIV-1 genome" The AIDS Knowledge 
Base http://hivinsite.ucsf.edu/akb/1997/03genome/index.html, March 1998 and 
Gottfredsson, M., 1997. 
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Figure 2. Life cycle of the HIV: 
 Source: Adapted from: https://www.aids.gov/hiv-aids-basics/just-diagnosed-with-hiv-
aids/hiv-in-your-body/hiv-lifecycle/ and 
http://www.bioafrica.net/manuscripts/RyanProteomics.pdf 
1. Entry: HIV binds to a specific type of CD4 receptor and a co-receptor on the surface 
of the CD4 cell. HIV fuses with the host cell (CD4 cell) and release its genetic material 
into the cell. 
2. Reverse Transcription: reverse transcriptase makes DNA from viral RNA, so it can 
be integrated into the host DNA. 
3. Integration: Viral DNA enters the nucleus of the CD4 cell and uses an enzyme called 
integrase to integrate itself into the host’s genetic material, where it may “hide” and 
stay inactive for several years. 
4. Transcription: When the host cell becomes activated, and the virus uses host’s 
enzymes to transcribe viral genes. 
5. Assembly: Protease cuts the longer HIV proteins into individual proteins. These 
proteins are later assembled. 
6. Budding and maturation: Virus buds out of the cell with part of host cell membrane. 
This outer part covers the virus and contains all of the structures necessary to bind to a 
new CD4 cell and receptors and begin the process again. 
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Effects of HIV on the gastrointestinal tract 
Gastrointestinal (GI) disease is a major manifestation of HIV and accounts for a majority 
of presenting symptoms of acquired immune deficiency syndrome (AIDS) worldwide and 
to a greater extent in developing countries (Brenchley, 2013; Estes et al., 2010). The HIV 
virus is mostly transmitted sexually through mucosal surfaces. In the GI tract, transmission 
may occur via the anorectal or possibly via the oral mucosa. Mother to child transmission 
occurs mainly via the oral route during breastfeeding. Even though breaks in mucosal 
surfaces can facilitate transmission, transmission has been shown to occur via intact 
mucosa (Brenchley & Douek, 2008. Rectal and colon mucosa are lined by a single 
epithelial layer making it easy for transmission. Anal mucosa has dendritic cells (DCs), 
which do not express CD4 or the chemokine receptor type 5 (CCR5). The mechanism of 
anal transmission is not well understood. Even though M cells are suggested to play a role 
in this transmission there is still no definitive study, which confirms this (Brenchley & 
Douek, 2008).  
The HIV virus is recognized by CD4 receptors expressed on T cells and 
macrophage/monocyte lineage cells along with a co-receptor CCR5 or chemokine receptor 
type 4 (CXCR4)). CD4/CCR5 positive cells are highly expressed in the gut and are 
primary targets of the HIV virus (Brenchley & Douek, 2008). Meanwhile 
macrophage/monocyte lineage cells are important reservoirs contributing to latency.  
Clinical manifestations of HIV in the GI include diarrhea, weight loss and GI ulcers 
(Bhaijee, Subramony, Tang, & Pepper, 2011). HIV infection is characterized by epithelial 
cell apoptosis and alterations in genes responsible for epithelial repair and regeneration and 
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an upregulation of genes associated with inflammation (Estes et al., 2010). Moreover, HIV 
infection is accompanied by increased depletion of Th17 cells that are responsible for 
enterocyte homeostasis and production of microbial defensins both of which are important 
in regulating intestinal mucosa. Alteration in homeostasis may also occur due to influx of 
cytotoxic T lymphocytes (CTL) (Brenchley et al., 2008; Brenchley, 2013; Klase et al., 
2015). Recent studies have shown that there is dysbiosis of gut microbiota during HIV 
infection. This dysbiosis is strongly linked to bacterial translocation and local activation 
and inflammation (Ciesielczyk & Thor, 2013; Grenham, Clarke, Cryan, & Dinan, 2011; 
Klase et al., 2015; Vujkovic-Cvijin et al., 2013). HIV causes immune activation that results 
in structural changes in the intestinal mucosa causing intestinal epithelial breakdown. 
Natural hosts of simian immunodeficiency virus (SIV), the African green monkeys and 
Sooty mangabey show rapid loss of CD4 CCR5 cells but recover implying that initial loss 
in these cells alone is not sufficient to drive progression to AIDS (Brenchley et al., 2008). 
Immune activation has been shown to be one factor that contributes to disease progression. 
Even though the mechanism by which bacterial translocation causes immune activation is 
unclear, studies have shown strong associations between bacterial translocation and 
immune activation. (Shan & Siliciano, 2014). With the advent of combined antiretroviral 
therapy (cART), viral replication is significantly reduced, and patients are living longer, 
but individuals treated with cART still have a higher mortality rate than uninfected people. 
This higher mortality rate is associated with continued immune activation that may be due 
to bacterial translocation (Klatt, Funderburg, & Brenchley, 2013; Sandler et al., 2011a)  
 
  
7 
 
 
 
 
 
 
Figure 3. Schematic presentation of viral and microbial translocation across epithelial 
barrier. (1) Uninfected gut epithelium: gut lumen contents separated from gut wall.  
(2)- (3) HIV infection leads to loss in integrity of epithelial membrane. 
(4)- (5) Infiltration of HIV virus and gut bacteria into lamina propria and infection of 
lamina propria cells.  
(6) Release of Tat by infected cells.  
(7) Modulation of enteric neurons by Tat. 
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Lipopolysaccharide (LPS) 
 
The rate of bacterial translocation from the gut lumen to extra intestinal organs can be 
assessed directly, by measuring the amount of bacterial products or indirectly by 
measuring the receptors or antibodies to which these products bind (Giulia Marchetti et al., 
Clin Microbial Rev., 2013). Lipopolysaccharide (LPS) is a component of the cell 
membrane of gram-negative bacteria that is frequently used to quantify bacterial 
translocation. It is recognized as a pathogen associated molecular pattern (PAMP) by Toll 
like receptor 4 (TLR4). LPS is made up of three molecules: A hydrophobic section (Lipid 
A), a hydrophilic core polysaccharide chain (composed of an inner and an outer core) and a 
hydrophilic O-antigenic oligosaccharide that is specific to the bacterial type.  The Lipid A 
molecule is responsible for LPS’ biological effects. LPS interacts with several mammalian 
proteins in order to stimulate the immune system. These proteins include: LPS binding 
protein (LPB), CD14 and the MD2/TLR4 complex. LBP is a soluble protein, which binds 
to LPS and facilitates the binding of LPS to CD14. There are two types of CD14: Soluble 
(sCD14) and membrane bound (mCD14) CD14. CD14 facilitates the binding of LPS to the 
MD-2/TLR4 complex. Upon binding and recognition of LPS by TLR4, a MyD88 and/or 
TRIF dependent signaling cascade is activated which results in the release of pro-
inflammatory cytokines and/or type I interferons respectively(Lu, Yeh, & Ohashi, 2008a; 
Plociennikowska, Hromada-Judycka, Borzecka, & Kwiatkowska, 2015a; Rhee, 2014). 
Also, a non-canonical pathway has been reported in which, cytosolic LPS is able to bind to 
murine caspase 11 or the human homolog, caspase-4/caspase-5 to induce pyroptosis and 
antibacterial responses to eliminate the invading pathogen. Excessive activation of this 
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pathway is thought to lead to septic shock (Hagar, Powell, Aachoui, Ernst, & Miao, 2013; 
Shi et al., 2014; Yang, Zhao, & Shao, 2015). 
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Figure 4. Schematic of the basic structure of lipopolysaccharide: LPS consists of three 
regions: from the bottom, lipid A, core sugars, and O-antigen, which consists of repeating 
units of oligosaccharides (Ogawa, T. 2007). 
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Figure 5.  Activation of TLR4 by LPS. LBP binds to LPS facilitating its transfer to 
CD14. CD14 transfers LPS to TLR4/MD-2 complex. The TLR4 receptor oligomerizes and 
recruits downstream effectors by interacting with TIR domains. MyD88 associates with 
TIR domain recruiting IRAK, which is activated by phosphorylation. Activated IRAk 
associates with TRAF6 which signals to activate NF-κB leading to the production of 
cytokines. A TRIF-dependent pathway can also be activated leading to the internalization 
of TLR4and ending up in regulating the production of type I interferons(Plociennikowska, 
Hromada-Judycka, Borzecka, & Kwiatkowska, 2015b). 
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HIV-1 trans-activator of transcription (Tat) 
In addition to direct effects of the HIV virus on the gut, indirect injury occurs as a 
consequence of cellular and viral toxins released by infected cells. One such toxin is HIV-1 
trans-activator of transcription (Tat). Tat is a 14 KDa protein that is one of the first proteins 
to be expressed after HIV infection and regulates the transcription of the HIV virus. It is an 
RNA binding protein that binds to trans-activator response elements (TAR) hairpin on the 
nascent HIV-1 RNA transcript. Upon binding it enhances the processivity of polymerase II 
and thus stimulates efficient elongation of the viral transcript allowing for full-length 
transcripts to be produced (Ott et al., 2004). The Tat protein is 86 to 102 amino acids long 
and is encoded by two exons. Exon 1 encodes the first 72 amino acids, which exhibits full 
trans-activating activity and contains an arginine-lysine-rich region (amino acid 49-57), 
which is important for nucleic acid binding of Tat. The other exon encodes the C terminal 
portion containing about 14 amino acids (73-86) which are not important for trans-
activation but play an important role in binding of extracellular Tat to integrins. Intact 
infected cells have been shown to release Tat (Chang, Samaniego, Nair, Buonaguro, & 
Ensoli, 1997a). Serum concentrations of Tat are in the nanomolar range in HIV infected 
individuals even though this concentration is believed to be higher around infected cells 
due to the fact that Tat is adsorbed on cell surfaces (Goldstein, 1996; Urbinati et al., 2009; 
Westendorp et al., 1995; Xiao et al., 2000). Extracellular Tat can be taken up by other cells 
and have been shown to modulate cellular functions (Chang, Samaniego, Nair, Buonaguro, 
& Ensoli, 1997b; Liu et al., 2000; Ma & Nath, 1997; Sabatier et al., 1991).  
  
13 
Tat has previously been shown to contribute to GI pathogenesis of HIV. Canani et al 
(Canani et al., 2006) showed that Tat inhibited glucose uptake in enterocytes by SGLT-1 
missorting and thus may contribute to diarrhea of unknown origin (Canani et al., 2006). 
Tat has also been shown to induce calcium-dependent chloride ion secretion in human 
colonic mucosa and in enterocytes, inhibit enterocyte proliferation and induce enterocyte 
apoptosis (Buccigrossi et al., 2011; Canani et al., 2003). To the best of our knowledge, this 
is the first study that assesses the effects of Tat on the enteric nervous system. 
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Figure 6. Primary structure of HIV Tat protein. Region I: Proline-rich region: 1 – 21 
residues (red). Region II: Cysteine-rich region: residues 22 – 37 (green). Region III: Core 
region: residues 38 – 48 (blue). Region IV: Basic region: residues 49 – 59 (orange). Region 
V: Glutamine-rich region: residues 60 – 72 (purple). Regions I to V are encoded by the 
first exon. Region VI is encoded by the second exon(Johri, Mishra, Chhatbar, Unni, & 
Singh, 2011).  
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The enteric nervous system (ENS) 
HIV is characterized by severe GI dysfunction including diarrhea, increased permeability 
and motility disorders. The GI processes that are affected are regulated by the enteric 
nervous system (ENS). The ENS consists of enteric neurons and glia arranged in two main 
ganglionated plexii: the myenteric plexus, found between the outer longitudinal and inner 
circular muscle and the sub mucosal plexus found between the circular muscle and the 
mucosa. The myenteric plexus forms a network of neurons that line the entire GI tract 
around the circumference though it may vary in size, shape and orientation from one part 
of the GI tract to another and between species. The submucosal plexus on the other hand 
only forms ganglionated plexuses in the small and large intestines and forms scattered 
ganglia in the stomach and esophagus, which are not ganglionated (Furness, 2012). 
 The ENS has been shown to play a role in regulating: blood flow, motility, digestion-by 
controlling gastric acid secretion, nutrient handling, absorption of fluids, and interacting 
with the immune and endocrine systems of the gut. (Furness, Oxford Press 2006). While 
the myenteric plexus is primarily involved with regulating GI motility, the submucosal 
plexus mostly functions in sensing the gut luminal environment, blood flow and gut 
epithelial integrity.  Indeed, enteric neurons together with enteric glia cells (EGCs) have 
been shown to regulate gut epithelial membrane integrity and thus regulate inflammation 
by releasing substances that maintain gut epithelial wall integrity (Chandra et al., 2005; 
Neunlist et al., 2003; Savidge et al., 2007). Knockout of glia in mice led to significant 
increases in pro-inflammatory cytokines (Savidge et al., 2007). 
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Three broad classes of enteric neurons exist: sensory (intrinsic primary afferents (IPANs)), 
interneurons and motor neurons. Neurons can also be excitatory or inhibitory based on the 
neurotransmitter secreted by the neuron. The enteric nervous system functions 
autonomously even though functions such as digestion require input from the central 
nervous system (CNS). EGCs outnumber enteric neurons and the neuron to glia ratio 
varies across regions of the ENS and across species (Neunlist et al., 2014). For a long time, 
enteric glia were thought to mainly function as support cells to enteric neurons but recent 
studies have shown that enteric glia are involved in several gastrointestinal functions and 
are severely affected in several pathologies of the GI tract.  EGCs when activated play a 
major role in antigen presentation and cytokine release (Ruhl, Nasser, & Sharkey, 2004). 
 Both EGCs and neurons have been shown to respond to inflammatory insults and to 
release cytokines (Coquenlorge et al., 2014; G. von Boyen & Steinkamp, 2010a; G. B. von 
Boyen et al., 2004). Not only does the ENS regulate inflammation but studies suggest that 
inflammatory and other insults can result in plasticity of the ENS (Barbara, Stanghellini, 
Cremon, De Giorgio, & Corinaldesi, 2008; Chaudhury, Shariff, Srinivas, & Sabherwal, 
2004; Kamm, Hoppe, Breves, Schroder, & Schemann, 2004; Tonini et al., 2005). 
Anderson et al (Anderson et al., 1990) reported intestinal ganglioneuritis in two children 
infected with HIV implying that the ENS may be involved in HIV pathogenesis.  Other 
clinical case reports also supported widespread involvement of the ENS in HIV 
pathogenesis(Anderson et al., 1990; Batman, Miller, Sedgwick, & Griffin, 1991a; Griffin 
et al., 1988). Orandle et al (Orandle, Veazey, & Lackner, 2007) had similar observations in 
animal models of SIV. They reported that even though the ENS was not a direct target of 
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SIV, enteric ganglionitis was observed in SIV infected macaques suggesting that the ENS 
may be playing a role in SIV pathogenesis (Orandle et al., 2007). Despite all of these 
studies directly implicating the ENS in HIV pathogenesis, little is known about the 
mechanisms underlying HIV enteric neuropathogenesis.  
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Figure 7. Organization of the enteric nervous system. Adapted from Furness, 2007 
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Aims 
The overall goal of this project was to study the effects of HIV-Tat on the ENS in order to 
broaden our knowledge of HIV neuropathogenesis which will help us find new targets for 
future HIV therapies. 
The specific aims were: 
Aim 1: To determine the effects of HIV-1 Tat on enteric neuronal excitability 
Aim 2: To determine the interaction of Tat with bacterial proteins (the case of LPS) on the 
ENS 
Aim 3: To determine the effects of Tat and it’s interaction with LPS on GI motility 
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Chapter II 
Methodology 
 
All experiments were conducted in accordance with the procedures reviewed and approved 
by the Institutional Animal Care and Use Committee (IACUC) at Virginia Commonwealth 
University. 
Isolation and culture of neurons from the adult mouse myenteric plexus 
Cells were isolated as described recently(Smith, Ngwainmbi, Grider, Dewey, & Akbarali, 
2013). After sacrificing mice, the ileum was removed and placed in ice-cold Krebs solution 
(in mM) (118 NaCl, 4.6 KCl, 1.3 NaH2PO4, 1.2 MgSO4, 25 NaHCO3, 11 glucose and 2.5 
CaCl2) bubbled with carbogen (95% O2 / 5% CO2). The ileum was divided into short 
segments and threaded longitudinally on a plastic rod. Strips of the longitudinal muscle 
containing the myenteric plexus (LMMP) were gently separated using a cotton-tipped 
applicator. LMMP strips were rinsed three times in 1 ml Krebs and centrifuged (350 x g, 
30 s). LMMP strips were then minced with scissors and digested in 1.3 mg/ml collagenase 
type II (Worthington) and 0.3 mg/ml bovine serum albumin in bubbled Krebs (37 °C) for 1 
h, followed by 0.05% trypsin for 7 min. Following each digestion, cells were triturated and 
centrifuged (350 x g for 8 min). Cells were then plated on laminin (BD Biosciences) and 
poly-D-lysine coated coverslips in Neurobasal A media containing B-27 supplement, 1% 
fetal bovine serum, 10 ng/ml glial cell line-derived neurotrophic factor (GDNF, 
Neuromics, Edina, MN), and penicillin/streptomycin. Half of the cell media was replaced 
every 2-3 days with fresh neuron media. 
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All chemicals and reagents were obtained from Sigma Aldrich (St Louis, MO), unless 
otherwise noted, except cell culture reagents, which were purchased from Gibco (Grand 
Island, NY) and the HIV Tat1-86 protein (Immunodiagnostics, Inc.).  Male Swiss Webster 
mice (25-30 g, Harlan Sprague Dawley, Inc.) or male and female doxycycline (DOX)-
inducible, HIV-Tat1–86 transgenic mice (25-30 g) were used. The HIV-Tat1–86 transgenic 
mouse model was developed on a C57BL/6J hybrid background and is described in detail 
elsewhere (Bruce-Keller et al., 2008). Briefly, the construct was generated using a 
tetracycline (tet) “on” system. Tat expression, which is under the control of a tetracycline 
responsive, glial fibrillary acidic protein (GFAP)-selective promoter, was induced with a 
specially formulated chow containing 6 mg/g DOX (Harlan, Product#: TD.09282, 
Indianapolis, IN), fed to both the Tat− controls and the inducible Tat+ mice. The inducible 
Tat transgenic mice (Tat+ mice) used in this dissertation express both GFAP-RTTA and 
TRE-Tat genes, while control Tat− mice express GFAP-RTTA but not the TRE-Tat gene. 
Mice were fed with doxycycline (DOX) containing chow for the specified times (3 days - 2 
weeks) to induce the expression of the Tat gene. The 3 days – 2 weeks DOX exposure 
duration is based on findings from previously published studies that show increased 
astrocyte activation and an increased percentage of neurons expressing active caspase-3 in 
the striatum, as early as 2 days of exposure to DOX (Bruce-Keller et al., 2008)  
Immunocytochemistry 
Isolated cells cultured for the specified times (4 days - 2 weeks) on coverslips were fixed 
in 4% formaldehyde for 30 min.  Cells were permeabilized with 0.01% Triton X-100 in 
PBS (30 min), and blocked with 10% goat serum (1 h).  Preparations were incubated with 
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the primary antibody overnight at 4 °C. Primary antibodies used were as follows: neuronal 
specific anti-βIII-tubulin (rabbit, Abcam ab18207-100, 1:100), anti-GFAP (Santa cruz, 
1:500) anti-Nav1.7 (mouse, Stressmarq, 1:300), Nav1.8 (mouse, Stressmarq, 1:300) and 
TLR4 (rabbit, Santa Cruz, 1:200). Following 3 washes in PBS, cells were incubated with 
the appropriate secondary antibodies; goat anti-rabbit Alexa 488 Dye (Molecular Probes, 
1:1,000, 1 h, RT) and goat anti-mouse Alexa 594 Dye (Molecular Probes, 1:1,000, 1 h, 
RT). Visualization was performed on an Olympus Fluoview Confocal Microscope and 
software (v5.0). 
Whole-cell patch clamp 
Myenteric neuronal cells were studied from 1-4 days in culture.  Coverslips containing 
cells were placed in an experimental chamber and perfused (1-2 ml/min) with an external 
physiological solution containing (in mM):  135 NaCl, 5.4 KCl, 0.3 NaH2PO4, 5 HEPES, 
1 MgCl2, 2 CaCl2, and 5 glucose.  Patch electrodes (2-4 MΩ) were pulled from 
borosilicate glass capillaries (Sutter Instruments, CA) and filled with internal solution 
containing (in mM): 100 K-aspartic acid, 30 KCl, 4.5 ATP, 1 MgCl2, 10 HEPES, and 0.1 
EGTA. In experiments to measure sodium channels, K-aspartic acid was replaced by Cs- 
Aspartate to block any outward potassium currents. Whole-cell patch clamp recordings 
were made with an Axopatch 200B amplifier (Molecular Devices, CA) at room 
temperature and pulse generation and data acquisition were achieved with Clampex and 
Clampfit 10.2 software (Molecuar Devices, CA). Neuronal excitability was determined in 
current clamp mode with current provided in 13 sweeps of 0.5 s duration ranging from –
0.03 nA to 0.09 nA in 0.01 nA increments. Current-voltage relationships were determined 
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in voltage clamp mode, in 16 0.5 s-sweeps beginning at –100 mV and increasing in 10 mV 
intervals to 50 mV. Current amplitudes were normalized to cell capacitance (pF) to 
determine current density. The threshold of action potentials was determined as the voltage 
at which the d (V)/d (T) function deviated from zero. Action potential height was 
determined by measuring the threshold to the peak of the action potential. Voltage-
dependence of steady-state inactivation and activation were determined and fit via 
Boltzmann’s distribution as described previously(Akbarali & Giles, 1993) 
In-cell western blot assay 
 
Analysis of Nav1.7 and Nav1.8 protein expression was performed by in-cell western blot 
assay. Enteric neurons were plated in 96 well plates. After three days in culture, cells were 
fixed (4% formaldehyde in 1 × PBS, 20 min at 25 °C), permeabilized (0.1% Triton in 1 × 
PBS, 4 washes for 5 min each at 25 °C with rotation) and blocked (0.5 × Odyssey Blocking 
Buffer), for 1 h at 25 °C with rotation. Primary antibodies: anti-Nav1.7 (mouse, 
Stressmarq, 1:300) and Nav1.8 (mouse, Stressmarq, 1:300) were diluted 1:100 in 0.5 × 
blocking buffer (50 µl per well) and allowed to incubate overnight at 4°C. Cells were then 
washed 3 × with 1 × PBS-Tween (0.1%) for 5 min at 25 °C with rotation, followed by the 
addition of secondary antibody: rabbit anti mouse, IRDye® 680RD and IRDye® 800RD, 
Licor Biosciences  (diluted 1:200 in 0.5 × blocking buffer) for 1 h at 25 °C. Following 
three additional wash cycles, wells were aspirated and the plates were scanned using the 
Licor Odyssey Scanner (Licor Biosciences). Data were normalized to β-III tubulin loading 
controls and presented as mean ± SEM responses with reference to controls (100% 
standard). 
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Gastrointestinal motility studies: 
Upper GI transit was determined by feeding age and weight matched tat transgenic mice 
with DOX chow for two weeks to activate the tat transgene after which they were fasted 
overnight. On the test day, mice were administered a charcoal gavage, 30 min later, they 
were sacrificed and the ileum removed carefully without artificially stretching the tissue. 
The total length and the leading edge of the charcoal meal were measured. Upper GI tract 
motility was determined by calculating % charcoal transit/ total ileum length. In a separate 
series of experiments, to avoid the interference of the DOX diet on GI effects, age matched 
mice were fed with DOX chow for 1 week after which the DOX chow was substituted for 
a regular chow for 3 weeks. This paradigm was used to avoid confounding effects of the 
loss of gastrointestinal microbiota by DOX treatment.  PCR was performed to confirm 
expression of the tat gene in the ileum after 3 weeks of DOX removal.  Gastric stasis was 
determined by dissecting out stomachs from age-matched Tat+ and Tat- mice 2 mm 
proximal to the lower esophageal sphincter and 2 mm distal to the pyloric sphincter. They 
were then immediately weighed and bathed in oxygenated physiologic Krebs solution. The 
stomach contents were emptied by flushing, blotted onto paper towel, and weighed again. 
The rate of gastric stasis was determined using the following equation(Asakawa et al., 
2003; Welsh, Enomoto, Pan, Shifrin, & Belik, 2013). 𝑁𝑒𝑡  𝑠𝑡𝑜𝑚𝑎𝑐ℎ  𝑐𝑜𝑛𝑡𝑒𝑛𝑡(  𝑔𝑎𝑠𝑡𝑟𝑖𝑐  𝑠𝑡𝑎𝑠𝑖𝑠)
= 𝑇𝑜𝑡𝑎𝑙  𝑠𝑡𝑜𝑚𝑎𝑐ℎ  𝑤𝑒𝑖𝑔ℎ𝑡 − 𝑒𝑚𝑝𝑡𝑦  𝑠𝑡𝑜𝑚𝑎𝑐ℎ  𝑤𝑒𝑖𝑔ℎ𝑡𝑏𝑜𝑑𝑦  𝑤𝑒𝑖𝑔ℎ𝑡  
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Overall GI transit was determined by counting the fecal pellet output. On test day (day 30), 
mice were placed in clean cages for 2 hours and the fecal pellets were collected and 
counted. (Anitha, Vijay-Kumar, Sitaraman, Gewirtz, & Srinivasan, 2012). The water 
content of the caecum was determined by dissecting out the caecum, collecting the caecum 
content, immediately weighing it, drying it by heating at 60ºC for 1 hour and reweighing it. 
The water content was determined by the following equation: 
𝑪𝒂𝒆𝒄𝒖𝒎  𝒘𝒂𝒕𝒆𝒓  𝒄𝒐𝒏𝒕𝒆𝒏𝒕 =𝑾𝒆𝒕  𝒎𝒂𝒔𝒔− 𝒅𝒓𝒚  𝒎𝒂𝒔𝒔𝒘𝒆𝒕  𝒎𝒂𝒔𝒔 ×𝟏𝟎𝟎 
Cytokine release 
Cytokine release was measured by Enzyme-linked immunosorbent assay (ELISA) kits 
(ebioscience, an affymetrix company, San Diego, USA). Supernatants were obtained from 
mouse primary neuron/glia cultures or from the enteric glia cells (CRL-2690 Rattus rattus) 
(Rühl,A. 2001) after treatment with HIV-1 Tat , LPS, CPG or a combination of both at the 
indicated time points and concentrations. Some experiments were also performed on 
supernatant from cells treated with Tat overnight to detect the cytokines tumor necrosis 
factor-alpha (TNF-α), interleukin-6 (IL-6), and the chemokine RANTES using ELISA 
(R&D Systems, Minneapolis, Minnesota, USA).  
RT-PCR 
RNA was extracted from the enteric glial cell line (CRL2690 (ATCC), a transformed EGC 
line isolated from adult rat myenteric plexus) using RNAqueous® Total RNA Isolation Kit 
(life technologies) or from mouse ileum or the LMMP using TRIZOL (Invitrogen, 
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Carlsbad, CA, USA) following manufacturer’s protocol. It was then quantified using 
spectrophotometer (BIORAD Smart Spec Plus). cDNA synthesis and subsequent 
polymerization was performed in a one-step using the iTaq Universal SYBR Green One-
Step Kit (Bio-Rad, Hercules, CA, USA).  The reaction mixture (20 µl) contained 200 nM 
forward primer, 200 nM reverse primer, 1x iTaq universal SyBR Green reaction mix, 1x 
iScript reverse transcriptase, and 200 ng total RNA. Real time PCR was performed using a 
MiniOpticon Real-Time PCR System (Bio-Rad, Hercules, CA, USA). Specific primers for 
IL-1β, IL-6, TNF-a, IL-1β, Nav1.3, Nav1.7 Nav1.8 and Nav1.9 were used. 18 s RNA was 
used as the internal control.  Experiments were performed in duplicates from three 
biological samples.  The mean normalized fold expression ± SEM were plotted. The 
primers used are included in table 1.  
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Table 1. Primers used for RT-PCR experiments 
 
 
Gene Forward primer Reverse primer 
Rat IL-6 5’-CCT GGAGTT TGT GAA CAA CT-3’ 5’-GGA AGT TGG GGT AGG 
AAG GA-3’ 
Rat TNF-α 5’-TGT CGA TGC CTG AGT GGA T-3’ 5’-AGG GAG GCC TGA GAC 
ATC TT-3’ 
Rat 18S 5’-GAT TAA AGT CCT ACG TGA TCT 
AAG TCC-3’ 
5’-TTC GTA ACT GGG AGA 
AAT TGT AAA-3’ 
Mouse 
Nav1.7 
5’-GCC TTG TTT CGG CTA ATG AC-3’ 5’-TCC CAG AAA TAT CAC 
CAC GAC-3’ 
Mouse 
Nav1.8 
 5′ GTG TGC ATG ACC CGA ACT GAT-
3 
5′-CAA AAC CCT CTT GCC AGT 
ATCT-3 
Mouse 18S 5’-TCA AGA ACG AAA GTC GGA GG-
3’ 
5’-GGA CAT CTA AGG GCA 
TCA C-3’ 
Mouse IL-6 5’-CTA AA GTC ACT TTG AGA TCT 
ACT C-3’ 
5’-TGT CCC AAC ATT CAT ATT 
GT-3’ 
Mouse TNF-
α 
5’-GTT GTA CCT TGT CTA CTC CC-3’ 5’-GTA TAT GGG CTC ATA 
CCA GG-3’ 
Mouse IL-1β 5’-GTA CAA GGA GAA CCA AGC AA-
3’ 
5-TGT TGA AGA CAA ACC GTT 
TT-3’ 
Rat MyD88 Santa Cruz MyD88 (r)-PR: sc-106986-PR Santa Cruz MyD88 (r)-PR: sc-
106986-PR 
Mouse  
NaV1.3 
5’-TTG GCT CCA AAA AAC CTC AG-3’ 5’-TTG AGA GAA TCA CCA 
CCA CA-3’ 
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MyD88 SiRNA Knock down 
To determine the role of MyD88 on Tat and LPS interactions, MyD88 SiRNA (MyD88 
siRNA (r): sc-106986) was used to knock down MyD88 in the enteric glial cell line (CRL-
2690) following the manufacturers protocol. Briefly, 2 x 105 cells were seeded in 6 well 
plates for 18-24 hours. At 60-80% confluence, cells were transfected with 2-8µl of the 
siRNA duplex for 6 hours after which 1mL of culture media containing 2 times FBS and 
penicillin/streptomycin was added and cultured for 18-24 hours. The transfection media 
was replaced with fresh culture media and cultured for 24 hours. MyD88 knock down was 
confirmed by RT-PCR using specific MyD88 primers. The effects of LPS and Tat on TNF-
α and IL-6 were determined using RT- PCR. 
NF-ΚB Assay 
To determine the role of NF-κB on Tat and LPS interactions, CRL-2690 cells were treated 
with the indicated viral and/or bacterial protein for the indicated times (0.5, 1, 2, 4, 6, 16) 
h. When NF-κB is activated, it translocates to the nucleus where it drives gene expression. 
The nuclear portions were extracted and nuclear/activated NF-κB p65 transcript was 
quantified using NF-κB p65 binding ELISA kit (Abcam). The amount of nuclear NF-κB 
represents the amount of activated NF-κB. 
Gastrointestinal Motility Monitor (GIMM) 
Colonic motility was measured using the Gastrointestinal Motility Monitor. We slightly 
modified the methodology reported by Barnes Kyra et al (Barnes, Beckett, Brookes, Sia, & 
Spencer, 2014). After euthanizing adult Tat transgenic mice, the colon was excised 
immediately and placed in an illuminated organ bath, continuously perfused with Krebs at 
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35.5 ± 0.5°C. The Krebs was constantly bubbled with carbogen gas (95% O2/5% CO2). 
The entire colon containing natural pellets was anchored with pins at the mesenteries of the 
anal and oral ends to prevent interfering with pellet movement and over-manipulation of 
the tissue. The remaining mesenteries were gently trimmed. Typically, it took ≤ 5 min 
from excising the colon until when the recording was started. The number of pellets 
expelled in 30 min was recorded and was used to determine the rate of colonic transit. The 
colonic transit rate was computed as the percentage of natural fecal pellets expelled during 
the recording time (30 min). The ileum was also excised starting immediately proximal to 
the caecum up to 8 cm proximal to the caecum. It was immediately put into a beaker 
containing warm Krebs at 35.5 ± 0.5°C. The contents were flushed with Krebs and then 
placed in an illuminated organ bath, continuously perfused with Krebs at 35.5 ± 0.5°C. The 
Krebs was constantly bubbled with carbogen gas (95% O2/5% CO2). The ileum was 
anchored with pins at the mesenteries of the proximal and distal ends to prevent over-
manipulating the tissue. The remaining mesenteries were gently trimmed. The ileum was 
allowed to acclimatize for 5 minutes before the recording was made. Typically it took ≤ 10 
minutes from excising the ileum till the recordings were started. Diameter readings were 
taken every 0.22 mm along the entire ileum segment every 0.0667 seconds for 300 
seconds. Using a program deigned on EXCEL VBA, diameter changes were determined by 
the following equation for each ileum segment for 5 min. 𝑫𝒊𝒂𝒎𝒆𝒕𝒆𝒓  𝒄𝒉𝒂𝒏𝒈𝒆 = 𝒅𝒊𝒂𝒎𝒆𝒕𝒆𝒓  𝒂𝒕  𝒕𝒊𝒎𝒆   𝒕+ 𝟏 −𝑫𝒊𝒂𝒎𝒆𝒕𝒆𝒓  𝒂𝒕  𝒕𝒊𝒎𝒆  (𝒕) 
The sum of diameter changes for the first 45 (1 cm) segments most proximal to the caecum 
was counted as the number of diameter changes of the proximal ileum. The sum of 
  
30 
diameter changes of the last 45 (1 cm) segments immediately proximal to the caecum was 
considered as the number of changes of the distal ileum. 
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Figure 8. Gastrointestinal Motility Monitor. Illuminated organ bath containing the tissue 
to be studied is continuously perfused with Krebs constantly bubbled with carbogen gas. 
Video recordings are taken with the help of a camera.  
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Bacterial translocation 
Bacterial translocation was determined by culturing mesenteric lymph node (MLN), spleen 
and liver. After euthanizing the mice, MLN, spleen and liver were aseptically collected and 
weighed separately. They were then placed in separate grinding tubes and homogenized by 
adding 9 parts of PBS containing 0.1 % tween 20 per gram of tissue (e.g. to 0.5 g of MLN 
add 4.5 mL of PBS containing 0.1 % tween 20). 100 µl of homogenate was plated in LB 
agar. Plates were cultured for 48 hours under aerobic conditions. Colonization was 
quantified as the number of colony-forming units (CFUs) per milliliter of homogenate. 
Assessment of neuronal pathology. 
Pathology of enteric neurons was assessed by evaluating the morphology of neuronal 
projections using a Zeiss Axio Observer Z.1 inverted microscope (Carl Zeiss) with an 
automated, computer-controlled stage encoder with environmental control (37°C, 95% 
humidity, 5% CO2). Enteric neuron/glia cells were isolated  from the ileum and colon and 
cultured in 12 well plates for 1 week. The cells were then treated with 100 nM Tat, 
100ng/mL LPS or a combination of both for 17 h. For each 12 well plate, six, non-
overlapping fields were randomly selected using a 63× objective. Neurons with a rounded 
cell body and projections were selected from each field. Swellings on axons and dendrites 
were counted/ unit length by two people who were blinded to the treatment conditions. 
Repeated-measure analyses were performed on six neurons per treatment per experiment; 
at least three independent experiments for each treatment were conducted. The data 
presented is an average of the number of swellings/ unit length obtained by two people and 
presented as the mean ± SEM. 
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Chapter III 
 
Aim 1: To determine the effects of HIV-1 Tat on enteric neuronal excitability 
 
This chapter has been previously published elsewhere  (Ngwainmbi J, De DD, Smith TH, 
El-Hage N, Fitting S, Kang M, Dewey WL, Hauser KF, Akbarali HI, J Neurosci. 2014) 
 
Introduction 
As described in the introduction, the GI tract harbors 80-90% of the lymphocytes of the 
body. It presents an important component of acquired immunodeficiency syndrome 
(AIDS) disease whereby, in addition to chronic diarrhea, alterations in structure and 
function occur as a result of the destruction of mucosal immunity, enhanced viral 
replication and prolonged inflammation (Handley et al., 2012; Lackner, Mohan, & Veazey, 
2009; Mohan et al., 2012; Orandle et al., 2007; Veazey et al., 1998). In fact, the mucosal 
CD4+ T-cell destruction within the lamina propria is detectable at earlier times than in 
peripheral blood (Brenchley et al., 2004; Lim et al., 1993; Mattapallil et al., 2005; 
Mavigner et al., 2012; Smit-McBride, Mattapallil, McChesney, Ferrick, & Dandekar, 
1998). AIDS progression is driven by significant damage to gut associated lymphoid tissue 
(GALT). Much of our understanding of neuropathogenesis in AIDS arises from work done 
in the brain while less is known of its effects on peripheral neurons (Cornblath & Hoke, 
2006; Johnson et al., 2013a; Lehmann, Chen, Borzan, Mankowski, & Hoke, 2011; Pardo, 
McArthur, & Griffin, 2001; Simpson & Olney, 1992).  
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HIV transcription is mainly controlled by Tat. Tat is an early regulatory protein, 86–102 aa 
in length (14-16 kDa). It plays an important role in viral transcription, replication and has 
also been implicated in inducing the expression of a variety of cellular genes as well as 
acting as a neurotoxic protein. It is released by intact infected cells (Chang et al., 1997b). 
In the CNS, the principal cell types harboring active infection are perivascular 
macrophages and microglia, and to a lesser extent astroglia (Ellis, Langford, & Masliah, 
2007; Gonzalez-Scarano & Martin-Garcia, 2005; Kaul, Garden, & Lipton, 2001; S. A. 
Yukl et al., 2013). Neurological defects persist even in HIV-infected individuals on 
combined antiretroviral therapy (cARTs) who are aviremic (McArthur, Steiner, Sacktor, & 
Nath, 2010). In the gut, as in the CNS, neuronal injury may be an indirect consequence of 
cellular and viral toxins released by infected cells. Once infected, limiting HIV replication 
alone may be inadequate to prevent neuronal impairment. With improved survival with 
cART, the manifestations of chronic exposure to low-levels of viral and cellular toxins 
associated with HIV-1 infection become increasingly evident—especially in the ileum(S. 
A. Yukl et al., 2013). Tat production from pre-integration HIV-1 DNA or during the early 
phase of transcription from integrated proviral DNA is largely unaffected by cART 
(Kilareski, Shah, Nonnemacher, & Wigdahl, 2009). 
Despite clinical evidence of altered gastric motor function and enteric ganglionitis in 
simian immunodeficiency virus (SIV) infected macaques (Konturek, Fischer, van der 
Voort, & Domschke, 1997; Orandle et al., 2007), the effects of HIV-1 on the ENS have not 
been well studied. In this aim, we examined the effects of Tat on enteric neuronal 
excitability and inflammatory cytokine release.  
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Results 
Tat increased enteric neuronal excitability 
Enteric neuronal excitability was assessed using current clamp experiments. The rheobase 
for action potential generation, number of action potentials evoked and the threshold 
potential were studied as determinants of neuronal excitability. The average resting 
membrane potential of neurons was -50.3 ± 0.6 mV (n=65) (Table 2). Current injection 
evoked single action potentials in all control cells and multiple action potentials at 
rheobase in some cells (6/19). However, when neurons were continuously perfused with 
100 nM Tat for up to 30 min, neuronal cells became increasingly excitable with a reduced 
rheobase and multiple action potentials elicited at rheobase (n=5) (Figure 9A). In neuronal 
cells pretreated with Tat (100 nM) for 17 h- 48 h in culture, the current required to evoke 
an action potential (rheobase) and the threshold potential for the upstroke of the action 
potential were significantly lower than controls. Also, 19 of the 20 cells evoked multiple 
action potentials (Table 2). Increase in neuronal excitability could also be seen by the 
presence of spontaneous action potentials in 4 cells with 0 nA current injection (Figure 
9B). There was no significant difference in resting membrane potential between Tat treated 
cells and controls (Table 2). To determine that this increase in neuronal excitability was a 
Tat specific effect, we treated neurons with heat inactivated Tat. These neurons were not 
significantly different from controls in terms of their excitability (Table 2). Next, we 
assessed the in vivo effects of Tat on enteric neuronal excitability. Neurons were isolated 
from Tat transgenic mice (Tat+) and control (Tat-) littermates expressing only the reverse 
tetracycline trans activator gene (Bruce-Keller et al., 2008). To confirm that Tat was 
  
36 
expressed in the ileum of these mice, RT-PCR experiments were performed on LMMP of 
both Tat+ and Tat- mice that were treated with DOX for 4 days. The tat gene was highly 
expressed in Tat+ mice (Figure 9C). Neurons isolated from Tat+ mice after 4 days of DOX 
treatment, fired multiple action potentials at significantly lower rheobase and threshold 
potentials than those isolated from Tat- mice (Figure 9D and Table 2). These data suggest 
that HIV-1 Tat either when perfused directly, treated overnight or exposed in vivo resulted 
in enhanced neuronal excitability.  
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Figure 9.  Tat increased enteric neuronal excitability: Representative traces showing 
current clamp recordings of a neuron in the absence and in the presence of 100 nM Tat (A). 
Increased neuronal excitability in response to 100 nM Tat is evidenced by an increase in 
the number of action potentials evoked. Action potentials were initiated after 30 pA current 
injection in the absence of Tat and 10 pA after continuously perfusion with 100 nM Tat, n 
= 5. Spontaneous action potentials were recorded in 4 neurons post Tat exposure (B). An 
RT-PCR experiment showing that tat gene is expressed in Tat+ LMMP and absent in Tat- 
LMMP (C). Neurons isolated from Tat+ transgenic mice were also more excitable than 
Tat- mice (D). Grey line indicates response recorded at rheobase. 
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Table 2.  Tat mediated increase in neuronal excitability is Tat specific and long 
lasting. Whole cell patch clamp experiments in current clamp mode on neurons pretreated 
with 100 nM Tat for 17 h to 48 h. These neurons fired a statistically significant higher 
number of multiple action potentials and at lower rheobase and action potential thresholds 
compared to controls. Neurons treated with heat inactivated Tat were less excitable 
compared to Tat pretreated and as excitable as controls (untreated neurons). Neurons 
isolated from Tat+ mice were also more excitable that Tat- mice neurons. Significance 
determined via paired t-test (p < 0.05).  
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Tat produced a leftward shift of the Boltzmann’s activation curve of sodium channels 
Sodium currents were measured in voltage clamp studies with cesium (Cs) in the pipette 
solution as reported by Smith et al (Smith, Grider, Dewey, & Akbarali, 2012). The current-
voltage relationship of sodium currents was shifted to the left upon overnight Tat (100 nM) 
treatment (Figure 10A). There was no difference in the current density. In order to 
determine the effects of short-term exposure (17 h) of neurons to Tat on the voltage 
dependence of steady-state activation/ inactivation of sodium channels, we used a double-
pulse protocol in which a variable conditioning pulse was applied from −100 mV to +50 
mV in 10 mV increments, for 50 ms followed by a test pulse to 0 mV. For a conventional 
time- and voltage-dependent Hodgkin-Huxley conductance, the steady-state inactivation 
curve describes the relative number of available Na+ channels as a function of voltage. The 
resultant sigmoidal curve was fit to a Boltzmann distribution (Figure 10B). The V0.5 of 
activation, the voltage at which half of the channels are activated, was -29.08 ± 0.6 mV 
with a slope factor of 4.5 ± 0.5 mV for control neurons and -38.5 ± 0.8 mV with a slope 
factor of 1.9 ± 1.0 mV for Tat treated neurons (Figure 10 B). There was a significant 
leftward shift in the activation curve of sodium channels indicating that channels were 
activated at more negative membrane potentials. Consistent with this, sodium currents 
activated at 10 mV more negative (-50 mV) in Tat (100 nM) pretreated cells (t-test, 
p<0.05) (Figure 10 A and C) compared to controls (-40 mV). There was no significant 
change in the inactivation curve upon treatment with Tat. The V0.5 for inactivation was -
36.9 ± 0.8 mV for controls and -39.5±0.1 mV for Tat treated neurons (Figure 10 B and D).   
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Figure 10. Tat changes the steady state voltage dependence of activation of sodium 
channels. Na+ channel activation/inactivation were examined using whole cell patch clamp 
experiments in voltage clamp mode and using a double-pulse protocol in the presence and 
absence of 100 nM Tat and without Tat (control). Cs+ is present in the internal solution to 
block outward K+ current. Current density/voltage curve of controls (untreated cells) and 
Tat pretreated neurons (A) Boltzmann curve analysis of inactivation and activation of Na+ 
indicate a leftward shift of the activation curve in response to Tat (B), indicated by a 
significant difference in V0.5 of activation (C). No significant difference in V0.5 of 
inactivation (D). Significance is determined via t-test (p < 0.05). 
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Tat selectively modulates sodium channel isoforms 
 
 
To date, nine mammalian pore forming alpha-subunit isoforms (Nav1.1-Nav1.9) of sodium 
channels have been cloned and functionally characterized with a tenth (Nax) isoform 
appearing to be gated by sodium ion concentration. Nav1.1, Nav1.2, Nav1.3 Nav1.4 and 
Nav1.7 are tetrodotoxin (TTX) - sensitive whereas Nav1.5, Nav1.8 and Nav1.9 are TTX- 
resistant. In the presence of internal Cs+, fast inward sodium currents were elicited positive 
to +40 mV from Vh-60 mV. Currents were markedly reduced in the presence of 1 µM TTX 
but not completely abolished. TTX-sensitive components were obtained by subtracting 
TTX resistant sodium currents from the total sodium currents (Figure 11A). The mRNA 
for Nav1.3, Nav1.7, Nav1.8 and Nav1.9 were examined by quantitative polymerase chain 
reaction (Q-PCR) of LMMP that were treated with Tat (100 nM) for 30 min or 2 days. 
There was no difference in Nav1.7 and Nav1.8 mRNA expression after 30 minutes of Tat 
treatment (Figure 11B,C). After 2 days treatment with Tat, the mRNA for Nav1.7 and 
Nav1.8 were significantly enhanced. Nav1.3 and Nav1.9 were not significantly different 
between Tat treated and controls (Figure 11D). These data suggest that Tat significantly 
increased transcription of sodium channel isoforms upon longer treatment and that Tat’s 
effect is isoform specific. Similar findings were seen in LMMP preparations of Tat 
transgenic mice (Figure 11E) where mice containing the tat gene, i.e. Tat+ mice expressed 
significantly higher Nav1.7 and Nav1.8 mRNAs compared to control transgenic mice (Tat-
).   
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Figure 11. Tat transcriptionally modulates Nav1.7 and Nav1.8. Representative raw 
traces of voltage- clamp experiments showing the presence of tetrodotoxin (TTX) sensitive 
and resistant sodium channels in neurons isolated from the adult mouse ileum (A) Q-PCR 
of LMMP preparation after 30 min Tat treatment. Nav1.7 and Nav1.8 mRNA levels are not 
changed (B & C). After long term exposure (2-3 days) to Tat, Nav1.7 and Nav1.8 mRNA 
levels are significantly increased but Nav1.3 and Nav1.9 levels are not affected by Tat 
pretreatment (D). Significantly higher Nav1.7 and Nav1.8 mRNA are observed in Tat+ 
compared to Tat- LMMP (E). Significance determined via ANOVA followed by 
Bonferroni’s posthoc test (p < 0.05).  
* 
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Tat up regulates Nav1.7 and Nav1.8 protein levels in enteric neurons 
 
To examine the protein expression of these channels on enteric neurons, cells were grown 
on coverslips for 7 days to allow for significant neurite outgrowth. The expression of 
Nav1.7 and Nav1.8 were determined by immunohistochemistry.  Nav1.7 was predominantly 
expressed on the cell membranes of neuronal cell bodies whereas Nav1.8 were mostly 
expressed on neuronal projections (Figure 12 A and 12B). To determine the effects of Tat 
on Nav1.7 and Nav1.8 protein levels, we performed in- cell western blot analyses. Enteric 
neurons were treated with 100 nM Tat for 3 days after which they were fixed with 
formaldehyde, permeabilized with 0.1% triton and exposed to Nav1.7 and Nav1.8 specific 
antibodies. These cells were co-stained with β-III tubulin as a loading control. There was a 
15% and 58% increase in Nav1.7 and Nav1.8 protein levels respectively in Tat treated cells 
compared to controls (Fig 12 C- F).  
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Figure 12. Nav1.7 and Nav1.8 are expressed on 
enteric neurons and are up regulated by Tat:  
Representative Immunocytochemistry staining showing 
β-III tubulin (green), neuronal marker and in red 
Nav1.7 (A) and Nav1.8 (B), sodium channel isoforms. 
Sodium channel isoforms co-localize with neurons and 
are membrane bound. In-cell Western blot analysis of 
isolated enteric neurons, with specific antibodies 
detecting Nav1.7 and Nav1.8 β-III tubulin was used for 
normalization. Background wells were incubated with 
secondary antibody but no primary antibody (C, E). 
The histogram represents the average of three sets of 
quantitative data, demonstrating the percentage 
induction of Nav1.7 and Nav1.8, respectively upon 72 
h treatment with 100 nM Tat. Data were normalized 
against the β-tubulin signal as mean ± SEM (n = 3). * 
VS Control (p < 0.05). Analysis for Tat treated wells 
showed a 15.9% increase in Nav1.7, and a 58.4 % 
increase in Nav1.8 expression as compared to the 
control (D, F). 
 
  
45 
Tat up regulates sodium current density 
The current–voltage relationship of sodium currents showed significantly higher sodium 
current densities in neurons isolated from Tat+ compared to those isolated from Tat- mice. 
This higher current density was associated with a loss of voltage-control evident in the 
current-voltage relationship (Figure 13A). Reducing extracellular Na+ was not sufficient to 
avoid the loss of voltage-control (Figure 13B). Adequate clamp was also not achievable in 
Tat+ neuronal cells that were in culture for only one day and mostly round in shape (to 
avoid axonal sprouting artifacts and provide for better spatial clamp), and using wider 
pipette tips (1.5 – 2 MΩ). This indicated that long-term exposure to Tat in vivo enhanced 
sodium channel expression making it difficult to adequately clamp these neurons.   
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Figure 13. Tat+ neurons had higher sodium current densities compared to Tat-. 
Current density/voltage curves of Tat+ and Tat- neurons at 140 mM (A) and 82 mM (B) 
bath solution NaCl concentration. Tat+ neuron had higher sodium current densities.  
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Tat up regulates pro-inflammatory cytokines 
To determine Tat’s effect on inflammation in the GI tract, pro-inflammatory cytokines 
were measured in Tat treated and control (untreated) enteric neuronal cells. Cultured 
neurons/glia co-cultures were exposed to Tat for overnight after which, the supernatant 
was removed and analyzed by ELISA to quantitatively assess the release of the cytokines 
TNF-α, IL-6 and the chemokine RANTES. Tat significantly increased RANTES and IL-6 
release (p < 0.05) but did not have an effect on TNF-α levels (Figure 14 A-C). Similarly, 
RANTES and IL-6 but not TNF-α expression were enhanced in the ileum of Tat+ (p < 
0.05). In addition, Tat+ transgenic LMMP preparations had 3 fold higher IL-1β mRNA 
levels than Tat- (Figure 14D).  
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Figure 14. Tat selectively upregulates pro-inflammatory cytokines. ELISA assay, 
assessing pro-inflammatory cytokine release. Tat increases RANTES and IL-6 levels but 
has no effect on TNF-α levels (A-C). A RT-PCR ,showing increased levels of IL-1β (D). 
Significance determined via Student t-test. 
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Discussion of aim 1 
The GI effects of HIV infection include alterations in structural integrity, diarrhea, and 
motility disorders.  These effects are not mutually exclusive and may involve both direct 
effects of the HIV virus and its proteins and those due to opportunistic infections following 
breakdown of the epithelial barrier and immunosuppression within the lamina propria. 
Neuronal injury largely results from the effects of neurotoxic factors, including viral 
proteins Tat, gp120 and Nef (van Marle et al., 2004). The present study shows that Tat can 
directly affect enteric neurons. Tat exposure leads to increased neuronal excitability that 
occurred within 30 min. Two effects of Tat on sodium currents were observed that might 
account for enhanced excitability, 1) a shift in the activation kinetics of the sodium 
channel, and 2) enhanced expression of Nav1.7 and Nav1.8. Tat also enhanced pro-
inflammatory cytokine release. To our knowledge, this is the first study that evaluates the 
effects of Tat on enteric neuronal excitability and also highlights the role of sodium 
channel expression and kinetics in Tat mediated effects. The direct effects of Tat on 
neuronal excitability have been previously examined in human fetal brain cells, cultured 
rat cerebral cortex neurons and in dorsal root ganglia (DRG) neurons (Brailoiu, Brailoiu, 
Chang, & Dun, 2008). In fetal brain cells, Tat induced membrane potential depolarization 
that was likely due to activation of the non-selective cation channel. In DRG neurons, the 
increased excitability may partly result from inhibition of Cdk5, although concentrations of 
Tat used (20 µM) were much higher than used in our present study (100 nM). The 100 nM 
concentration was chosen from a range that elicited functional deficits in glia and neurons 
similar to those occurring in HIV-1, and that are considered to reflect levels seen under 
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pathological conditions (El-Hage et al., 2005; Nath, Conant, Chen, Scott, & Major, 1999; 
Perry et al., 2010; Singh et al., 2004). In enteric neurons, we found that increased 
excitability is seen within 15 min and remains when examined in Tat transgenic mice. 
However, the mechanisms may differ. After short term exposure (17 h) to Tat, the steady-
state voltage dependence of activation of the sodium channel currents is shifted to the left, 
while at longer times (2 weeks DOX); there is an additional enhancement of sodium 
current density due to increased expression of Nav1.7 and Nav1.8. The increase in sodium 
current density resulted in significant loss of voltage control. We hypothesize that this is 
due to enhanced expression of Nav1.8 that appears to be localized on neuronal projections 
and thus contributes to the inability to adequately control the voltage (Cummins, Rush, 
Estacion, Dib-Hajj, & Waxman, 2009). 
Voltage gated sodium channels play an important role in regulating neuronal excitability 
by producing the fast depolarization responsible for the upstroke of the action potential 
(Ekberg & Adams, 2006; Mantegazza, Curia, Biagini, Ragsdale, & Avoli, 2010). When 
neurons were exposed to Tat for a longer time (2 weeks DOX), sodium current densities in 
neurons isolated from Tat+ were significantly higher than those isolated from Tat- mice. 
These changes in sodium channel expression may have significant consequences in 
enhanced excitability following bacterial exposure as would occur in AIDS. More recently, 
Chiu et al. demonstrated that bacterial proteins activate Nav1.8-expressing nociceptive 
neurons in the DRG, thus modulating pain sensation (Chiu et al., 2013). Bacterial proteins 
released following epithelial barrier breakdown may similarly affect intrinsic sensory 
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neurons within the ENS and thus define a potential site of interaction between HIV and 
opportunistic bacteria. 
Another factor that has been shown to modulate enteric neuronal excitability is cytokines.  
IL-6 and IL-1β have previously been shown to increase enteric neuronal excitability (Xia 
et al., 1999). Experimental and clinical data show that GI inflammation is a serious and 
common problem in HIV infected individuals (Brenchley, 2013; Kotler, 2005). Higher 
levels of pro-inflammatory cytokines IL-6, IL-10 and IFN-γ have been reported in HIV 
patients (Kedzierska & Crowe, 2001). Studies in the CNS showed that Tat increased pro-
inflammatory cytokine release by a glia-mediated mechanism (El-Hage, Bruce-Keller, 
Knapp, & Hauser, 2008). In this study, Tat selectively increased IL-6, Il-10, IL-1β and 
RANTES release, but had no significant effect on TNF-α levels. The mechanisms 
underlying Tat-mediated increases in pro-inflammatory cytokine release in the gut is not 
yet well understood. The increase in cytokine release may also be contributing to and/or 
exacerbating the increase in neuronal excitability observed in Tat exposed neurons.   
Bacterial translocation and immune activation have been reported to underlie the local 
inflammation observed in HIV patients. The next set of studies were therefore undertaken 
to assess the role of bacterial proteins and their interaction with HIV-1 Tat on enteric 
neuronal pathogenesis in HIV AIDS.  
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Chapter IV 
Aim 2: To determine the interaction of Tat with other bacterial products (the case of 
LPS) on the ENS 
This chapter has been submitted for publication (Ngwainmbi,J.; Brun P.; Kang M.; 
Dewey,W.L.; Hauser,K.F.; Akbarali,H.I. HIV-1 Tat sensitizes lipopolysaccharide-induced 
inflammatory cytokines via TLR4 signaling in enteric glia (in review)) 
Introduction 
HIV infection is characterized by intestinal mucosal damage leading to increased 
translocation of bacteria and viruses into the gut wall thereby exposing other cells and 
organs to bacterial and viral proteins and predisposing to systemic immune activation 
(Fernandes et al., 2014; Klase et al., 2015; Marchetti, Tincati, & Silvestri, 2013; Vujkovic-
Cvijin et al., 2013). Not only is initial HIV pathogenesis affected by the rate of gut 
bacterial translocation and inflammation, but clinical and experimental data also suggest 
that increased translocation correlates with progression to AIDS (Kristoff et al., 2014; 
Sandler et al., 2011b). Even though significant progress has been achieved at developing 
combined antiretroviral therapy (cART), which is potent, efficacious and has fewer side 
effects to patients, effective control of gut bacterial translocation still remains a significant 
problem in HIV patients. In healthy individuals, immune cells in the mesenteric lymph 
nodes and lamina propria phagocytize these microbes. However, in HIV patients, who 
have compromised immune systems, these microbes are able to migrate elsewhere to extra-
intestinal organs and tissues. Several studies have suggested that microorganisms and 
microbial products from the lumen of the gut are responsible for immune activation and 
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inflammation (Sandler et al., 2011b; Vujkovic-Cvijin et al., 2013).  One such microbial 
product that has been used as a tool to quantify the rate of bacterial translocation is 
lipopolysaccharide (LPS). LPS is a major component of the cell membrane of Gram-
negative bacteria. It is recognized by toll like receptor 4 (TLR4), which is expressed on 
immune and other cell types. LPS triggers the secretion of pro-inflammatory cytokines and 
can additionally regulate intestinal homeostasis (Guijarro-Munoz, Compte, Alvarez-
Cienfuegos, Alvarez-Vallina, & Sanz, 2014; Lu, Yeh, & Ohashi, 2008b).  
In the cART era, the pathologic consequences of HIV continue despite diminished viral 
loads, suggesting that neuroinflammation and tissue injury may result from viral products 
independent of viral replication, including the viral protein Tat (Ipp, Zemlin, Erasmus, & 
Glashoff, 2014; Johnson et al., 2013b; Wu, 2004). For example, while the number of 
infected blood macrophages in HIV-1 infected patients is only moderately increased, 
recent studies have suggested that it is the reduced phagocytic activity induced by the viral 
protein, Tat, which likely underlies the development of opportunistic infections 
(Debaisieux et al., 2015).  We have also recently shown that HIV-1 Tat profoundly affects 
the excitability of myenteric neurons, increases the levels of inflammatory mediators in the 
myenteric plexus and alters gastrointestinal motility (Ngwainmbi et al., 2014). 
Furthermore, HIV-1 Tat also sensitized enteric neurons to morphine (Fitting et al., 2015). 
In this aim, we sought to determine the interactive effects of Tat and LPS on enteric 
neurons and glia, and what role they plays in inflammation and GI disturbances that are 
commonly observed in HIV-infected patients. Most of HIV’s effects on neurons are 
believed to be indirect, i.e., the consequence of bystander effects of viral proteins and host 
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inflammatory responses (e.g., increased cytokines and oxyradicals) produced by infected 
immunocytes and glia. There is still no evidence of direct neuronal infection by HIV. We 
therefore studied the effects of HIV-1 Tat, an HIV regulatory protein secreted by intact 
infected cells, which has been shown to disrupt neuronal and glial function (Karn, 1999; 
Nath et al., 1996; Ngwainmbi et al., 2014) on LPS-mediated effects on ENS cells. 
Results 
Tat sensitizes enteric neuron/glia co-cultures to LPS mediated increase in IL-6, TNF-
α and IL-1β. 
To assess the in vitro effect of Tat and LPS on pro-inflammatory cytokine expression and 
release, we used; a) whole longitudinal muscle myenteric plexus (LMMP) preparations, b) 
primary cultures of neurons and glia isolated from the adult mouse ileum (Figure 15A) and 
c) the CRL-2690 enteric glia cell line.  
We first determined the effect of Tat and LPS on mRNA levels and release of pro-
inflammatory cytokines in the mouse ileum LMMP preparation. The LMMPs were treated 
with 100 nM Tat, 100 ng/mL LPS or a combination of both for 16 h. Neither Tat nor LPS 
increased TNF-α mRNA but when treated in combination, there was a significant (15 fold) 
upregulation of TNF-α mRNA levels (Figure 15B). 100 ng/mL LPS but not 100 nM Tat 
significantly increased TNF-α release. A combination of 100 nM Tat and 100 ng/mL LPS 
produced a further increase in TNF-α release (Figure 15C). Next, we assessed pro-
inflammatory cytokine release in neuron/glia co-cultures isolated from the adult mouse 
ileum. The cells were treated with Tat (100 nM) and LPS (100 ng/mL) for 16 h. Both Tat 
and LPS increased Il-6 release and showed further enhanced response when combined 
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(Tat+LPS) (Figure 15D). Similarly, the Tat/LPS sensitized interaction was also observed 
when Il-1β was measured (Figure 15E). These data indicate that Tat sensitized the effects 
of LPS on the release and expression of pro-inflammatory cytokines within the myenteric 
plexus.  
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Figure 15. Tat and LPS interaction in neuron- co-cultures isolated from adult mouse 
ileum. A) Representative confocal microscopic images of enteric β-III tubulin (green) 
neuron specific marker and glial fibillary protein (GFAP- red) showing the presence of 
neurons and glia isolated from the adult mouse LMMP. B) mRNA expression of TNF-α  of 
mouse LMMP treated with100 nM Tat, 100 ng/mL LPS or Tat+LPS for 16 h. C) TNF-α 
release from mouse LMMP treated with100 nM Tat, 100 ng/mL LPS or Tat+LPS for 16 h 
measured by ELISA D) IL-6 release of mouse neuron/glia co-cultures treated with 100 nM 
Tat, 100 ng/mL LPS or Tat+LPS for 16 h measured by ELISA. E) IL-1β release of mouse 
LMMP treated with100 nM Tat, 100 ng/mL LPS or Tat+LPS for 16 h measured by 16 h. 
n=3 P <0.05. One way ANOVA plus bonferroni’s post hoc test. *Vs CTL, # Vs Tat, ϕ Vs 
LPS. 
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Tat sensitizes enteric glia cells to LPS mediated increase in IL-6, TNF-α and IL-1β  
 
To further determine the role of enteric glia in Tat/LPS- mediated increase in pro-
inflammatory cytokines, we assessed the effects of Tat and LPS on the CRL-2690 enteric 
glia cell line. Enteric glia cells were treated with LPS, Tat or a combination of both at 
various concentrations (10, 100, 1000 ng/mL LPS) for 16 h. mRNA expression and 
cytokine release were measured. LPS dose-dependently increased IL-6 and TNF-α mRNA 
levels and this increase was drastically enhanced by co-treating the cells with 100 nM Tat. 
This sensitized response of enteric glia cells to LPS by Tat was most apparent at lower 
concentrations of LPS with no further combination effects observed at concentrations of 1 
µg/mL LPS (Figure 16 A&B). Furthermore, even though neither 100 nM Tat nor 10 ng/mL 
LPS affected TNF-α release in enteric glia, there was a significant enhancement of TNF-α 
and IL-1β release by enteric glia cells when treated in combination with Tat and LPS 
(Figure 16 C&D).  
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Figure 16. Tat and LPS interaction in the CRL-2690 enteric glia cell line. A) 
Normalized fold IL-6 mRNA expression of CRL-2690 enteric glia after treatment with 100 
nM Tat or 1, 10, 100 or 1000 ng/ mL LPS or Tat+(1, 10, 100 or 1000 ng/ mL) LPS for 16 
h. B) Normalized fold TNF-α mRNA expression of CRL-2690 enteric glia after treatment 
with 100 nM Tat or 1, 10, 100 or 1000 ng/ mL LPS or Tat+(1, 10, 100 or 1000 ng/ mL) 
LPS for 16 h. C) Release of TNF-α of CRL-2690 enteric glia after treatment with 100 nM 
Tat, 10 ng/mL LPS or Tat+LPS for 16 h. D) Release of IL-6 of CRL-2690 enteric glia after 
treatment with 100 nM Tat, 10 ng/mL LPS or Tat+LPS for 16 h. n=3 P <0.05. One way 
ANOVA plus bonferroni’s post hoc test. *Vs CTL, # Vs Tat, ϕ Vs LPS.
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Ilea of Tat-expressing (Tat+) mice were more sensitive to LPS induced increase in  
 
pro-inflammatory cytokines than Tat- mice. 
 
To study the in vivo effect of Tat and LPS on pro-inflammatory cytokine release, Tat 
transgenic mice were administered a doxycycline diet for 1 week to induce Tat expression. 
The diet was replaced with regular chow for 2 weeks to allow for recolonization by gut 
microbiota and to avoid doxycycline-induced effects. We have previously shown that 
following, one week of a doxycycline diet, the Tat gene was expressed and remained 
expressed even after discontinuation of the diet for 3 weeks (Ngwainmbi et al., 2014). The 
mice were administered LPS (50 µg/mL) in their drinking water for 1 week. RT-PCR and 
ELISA were used to assess the ilea of these mice for the expression of pro-inflammatory 
cytokines. In the ilea of Tat+ mice, LPS produced a 2.8-fold increase in IL-1β mRNA 
compared to a 1.5 fold increase observed in Tat- mice (Figure 17A). Also, LPS produced a 
7-fold increase in TNF-α mRNA, which was significantly higher than 1.9-fold increase in 
Tat- ilea. In ELISA experiments, LPS induced a higher increase of IL-1β protein levels in 
Tat+ ilea (3.1-fold increase) than in Tat- (2.3-fold increase) (Figure 17C). 
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Figure 17. Ilea of Tat-expressing (Tat+) mice were more sensitive to LPS induced 
increase in pro-inflammatory cytokines than Tat- mice. Normalized fold mRNA 
expression of TNF-α of ileum of Tat transgenic mice (A) or IL-1β (B) mRNA. LPS was 
administered at a dose of 50 µg/mL in drinking water for 1 week. Tat + mice were more 
sensitive to LPS induced increase in cytokine expression. C) IL-1β protein measured by 
ELISA. n=5-6. P<0.05 (students t test) *Vs Tat- or Tat+. 
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Tat and LPS but not Tat+LPS increased Nav1.7 and Nav1.8.  
In aim 1, we showed that Tat mediated increase in neuronal excitability and pro-
inflammatory cytokine release was accompanied by a significant upregulation of Nav1.7 
and Nav1.8 in enteric neurons. These sodium channel isoforms were expressed on neurons 
and not on enteric glia. To assess the effects of Tat and LPS on Nav1.7 and Nav1.8, we 
used whole LMMP. LMMP were treated with 100 nM Tat or 100 ng/mL or Tat+LPS. Both 
Tat and LPS increased Nav1.7 and Nav1.8 mRNA but a combination of both did not 
increase Nav1.7 or Nav1.8 any further (Figure 18 A&B). This suggests that the 
sensitization of LPS- induced increases in pro-inflammatory cytokine release and 
expression is not be mediated by a direct effect on these sodium channel isoforms.  
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Figure 18. Tat and LPS increased Nav1.7 and Nav1.8 but Tat + LPS did not further 
enhance Nav1.7 or Nav1.8. A) Normalized fold mRNA expression of Nav1.7 after 
treatment with 100 nM Tat, 100 ng/mL LPS or Tat+LPS for 16 h. B) Normalized fold 
mRNA expression of Nav1.8 after treatment with 100 nM Tat, 100 ng/mL LPS or Tat+LPS 
for 16 h. n=3 P<0.05(students t test) *Vs CTL.  
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Tat LPS interaction is Specific and not mediated via TLR9. 
To further determine if the sensitization of pro-inflammatory cytokine expression and 
release in enteric glia is specific to Tat and LPS, we used CpG an unmethylated 
dinucleotide, which signals through TLR9 to increase pro-inflammatory cytokines. 100 
ng/mL CpG significantly increased release of TNF-α in the CRL-2690 enteric glia cell 
line, but did not affect IL-1β levels (Figure 19 A&B). When treated in combination with 
Tat, there was no further increase in TNF-α or IL-1β (Figure 19 A&B). This indicates that 
the synergistic interaction of viral and bacterial proteins on enteric glia is not be mediated 
via TLR9. 
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Figure 19. Tat CpG interaction in the CRL-2690 enteric glia cell line. Normalized 
mRNA fold expression of IL-1β of CRL-2690 enteric glia (A) or TNF-α (B) after 
treatment with 100 nM Tat, 10 ng/mL CpG or Tat+CpG for 16 h. n=3 P<0.05(students t 
test) *Vs CTL. 
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Tat LPS interaction is TLR4 mediated. 
 
Both enteric neurons and glia express TLR4 (Figure 20A&B). To determine the 
involvement of TLR4 in this enhanced response to LPS by Tat, primary neuron/glia 
cultures were isolated from TLR4 knockout mice.  The primary cultures were treated with 
Tat and LPS for 16h.  Neither 100 nM Tat nor 100 ng/mL LPS nor a combination of both 
(Tat+LPS) increased IL-1β levels (Figure 20C). The sensitization effect was blocked by 
knockout of TLR4. This indicates that TLR4 plays an important role in Tat-LPS 
interactions in the gut. 
We then sought to determine the role of MyD88, an adaptor protein downstream of TLR4 
signaling. Interestingly, in glia cells treated with siRNA for MyD88, the expression of 
TNF-α was significantly reduced in basal conditions.  The effects of both Tat and LPS 
were blocked in cells with MyD88 siRNA (Figure 20D). The knock down of MyD88 also 
prevented the sensitizing effects of the Tat/LPS combination (Figure 20E&G).  
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Figure 20. Tat LPS interaction is TLR4 mediated. A) Representative confocal 
microscopic images of enteric β-III tubulin (green) neuron specific marker and TLR4 (red) 
showing the expression of TLR4 on neurons. B) Representative confocal microscopic 
images of enteric GFAP (green) glia specific marker and TLR4 (red) showing the 
expression of TLR4 on enteric glia. C) ELISA showing release of IL-1β by neuron-glia co-
cultures isolated from TLR4 knockout mice. Cells were treated with 100 nM Tat, 100 
ng/mL LPS or Tat+LPS for 16 h. D) RT-PCR showing knock down of MyD88 in CRL-
2690 enteric glia. E) RT-PCR of CRL-2690 enteric glia showing normalized fold 
expression of TNF-α (F) or IL-6 (G) after treatment with 100 nM Tat, 10 ng/mL LPS or 
Tat+LPS for 16 h. 
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We next determined if the sensitization between Tat and LPS could also be observed on 
NF- κB activation. We found that LPS time dependently activates NF-κB with the highest 
amount of activation occurring at 4 h LPS treatment (Figure 21A).  100 nM Tat did not 
significantly increase NF-κB activation; however it sensitized the effects of low 
concentrations of LPS in inducing NF- κB activation (Figure 21B).  
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Figure 21. NF-κB activation. A) Optical density reading showing time course of NF-κB 
activation in CRL-2690 enteric glia treated with 100 ng/mL LPS. Measured as the amount 
of translocation of NF-κB in the nucleus. n=3, P<0.05(students t test) *Vs CTL. B) Optical 
density reading showing NF-κB activation in CRL-2690 enteric glia treated with 100 nM 
Tat and/or (1, 10,100, 1000) ng/mL LPS with Tat for 4 hours. n=3, P<0.05(two-way 
ANOVA) ** Vs LPS. 
  
69 
Effects of Tat and LPS on neuronal pathology. 
 
Neuron/glia co-cultures were treated with Tat and LPS for 17 h after which the number of 
dendritic swellings was counted to assess neuronal pathology induced by Tat and LPS 
(Figure 22 & Figure 23). Both 100nM Tat and 100 ng/mL LPS significantly injured 
neurons causing significantly higher numbers of dendritic swelling than controls. There 
was no further increase when these cells were treated with a combination of 100 nM 
Tat+100 ng/mL LPS. This occurred in neurons isolated from both the ileum and the colon 
of adult mice.   
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Figure 22: Representative phase contrast microscopy images of neurons isolated from 
the adult mouse colon treated with Tat, LPS or Tat+LPS 
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Figure 23 Representative phase contrast microscopy images of neurons isolated from 
the adult mouse ileum treated with Tat, LPS or Tat+LPS 
 
 
 
 
 
 
Control' LPS' Tat+LPS'
Tat'
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Figure 24: Effects of Tat and LPS on dendritic pathology. Number of dendritic 
swellings / unit length in the ileum (A) and colon (B) after indicted treatment for 17 h. 
mean ± SEM. P<0.05(one-way ANOVA plus Bonferroni's multiple comparisons test 
) * Vs CTL. 
A 
B 
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Discussion of aim 2 
Microbial translocation in HIV patients is now recognized as an important contributor of 
HIV pathogenesis. In the present study we demonstrate that the viral protein, HIV-1 Tat 
sensitizes to LPS-mediated pro-inflammatory cytokine increase and that this increase in 
inflammation significantly disrupts gastrointestinal motility.  We also show that both Tat 
and LPS significantly alter neuronal morphology leading to increased neuronal swelling. 
This interaction appears to be mediated via the TLR4 receptor.  Our findings point towards 
a novel interaction between viral and bacterial proteins in the enteric nervous system.   
Inflammation is known to directly correlate with the rate of viral replication and 
progression to AIDS in HIV patients (Kotler, Reka, & Clayton, 1993; Kotler, 2005; 
McGowan et al., 2004). The cells of the enteric nervous system regulate GI inflammation. 
Enteric neurons and glia have been shown to undergo structural and functional remodeling 
during GI inflammation (Brierley & Linden, 2014; Mawe, 2015; Venkataramana, 
Lourenssen, Miller, & Blennerhassett, 2015). In aim 1 we show that Tat directly modulates 
the function of enteric neuron/ glia co-cultures leading to an increase in pro-inflammatory 
cytokine release (Ngwainmbi et al., 2014). Also, Tat sensitizes enteric neurons to 
morphine-mediated decrease in sodium current density (Fitting et al., 2015). In this study, 
we show that Tat sensitizes LPS-mediated increases in pro-inflammatory cytokines both in 
vitro and in vivo.  
Enteric glia are a major component of the myenteric plexus. They have been implicated in 
the regulation of gut epithelial membrane integrity (Cheadle et al., 2013; Yu & Li, 2014), 
mucosal defense against gut bacteria (Matteoli, 2011) and GI inflammation (Cabarrocas, 
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Savidge, & Liblau, 2003; G. von Boyen & Steinkamp, 2010b; G. von Boyen & 
Reinshagen, 2011; G. B. von Boyen et al., 2004; G. B. von Boyen et al., 2011). Enhanced 
microbial translocation observed in Tat + mice may allow for potential increase in the 
inflammatory cytokines by stimulating cells that were not previously exposed to viral and 
bacterial products. The enhanced release of several pro-inflammatory cytokines by a 
combination of Tat and LPS in isolated myenteric neuron/glia co-cultures was confirmed 
in an enteric glia cell line and in the ilea of the Tat + transgenic mice. 
 
Sodium channels have been shown to play an important role in inflammation and pain 
signaling (Gudes et al., 2015; Hockley et al., 2014). Recently, bacterial components such 
as α-haemolysin and N-formylated peptide have been shown to excite Nav1.8 expressing 
neurons and thus modulate inflammation and pain (Chiu et al., 2013). Also, LPS has been 
implicated in the modulation of sodium channels on microglia following inflammation 
(Jung, Lee, Rhim, Oh, & Yune, 2013). The majority of sodium channels found in the 
enteric nervous system are expressed on enteric neurons. Interestingly, in this study we 
show that even though both Tat or LPS significantly up-regulated Nav1.7 and Nav1.8, 
Tat+LPS did not further enhance the expression of Nav1.7 and Nav1.8. This might imply 
that this Tat mediated sensitization is not mediated by their action on sodium channels.  
 
 TLR4 is the main receptor for LPS even though recent studies have suggested that 
caspases may serve as a receptor for LPS when LPS concentrations are high in the 
cytoplasm (Hagar et al., 2013; Shi et al., 2014). When LPS binds to TLR4, a MyD88 
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and/or TRIF dependent pathway is activated (Lu et al., 2008b). Activation of the MyD88 
dependent pathway leads to downstream activation of NF-κB, which drives the synthesis 
of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-1β (Lu et al., 2008b). 
Moreover, Tat has recently been shown to bind to the TLR4 receptor and to induce 
cytokine release in a TLR4 dependent manner (Ben Haij, Leghmari, Planes, Thieblemont, 
& Bahraoui, 2013). The enhancement in inflammatory cytokines observed after treating 
enteric neurons and/or glia with a combination of Tat and LPS in wild type mice, was 
absent in the TLR4 knockout mice, and when MyD88 was knocked down by siRNA. LPS 
concentration-dependently induced NF-κB activation and when treated in combination 
with Tat activated NF-κβ at a significantly higher level than each concentration. These 
data suggest that the interaction of Tat and LPS in the enteric nervous system appears to 
involve the TLR4 receptor. Tat did not further enhance CpG’s effect indicating that the 
sensitization effect does not involve modulation of TLR9.  A possible mechanism may 
involve allosteric modulation of the TLR4 receptor by Tat, thus enhancing the effect of 
LPS.   
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Chapter V 
Aim 3: To determine the effects of Tat and it’s interaction with LPS on GI motility. 
 
Part of this chapter has been submitted for publication (Ngwainmbi,J.; Brun P.; Kang M.; 
Dewey,W.L.; Hauser,K.F.; Akbarali,H.I. HIV-1 Tat sensitizes to lipopolysaccharide-
induced inflammatory cytokines via TLR4 signaling in enteric glia (in review)) 
Introduction 
Motility disturbances have been reported in various regions of the GI tract in HIV patients.  
Fried RL et al (Fried, Brandt, Kauvar, & Simon, 1994; Zalar, Olmos, Piskorz, & 
Magnanini, 2003) and Zalar AE et al (Fried et al., 1994; Zalar et al., 2003) reported 
problems in esophageal motility in HIV patients.  Moreover, delayed rates of stomach 
emptying (Neild et al., 2000) and abnormal small intestinal motility patterns (Batman, 
Miller, Sedgwick, & Griffin, 1991b) were reported in HIV patients. The mechanisms 
underlying this disturbed motility patterns in these patients are not yet well understood.  
Increase in intestinal inflammation has been shown to profoundly disrupt intestinal motility 
patterns in various inflammatory diseases (Bassotti & Villanacci, 2012; Bassotti et al., 
2014; De Winter, van den Wijngaard, & de Jonge, 2012; Ohama, Hori, & Ozaki, 2007). 
Mechanisms that have been put forward that could account for this abnormal motility 
include: changes in neuromuscular signaling, immune cells such as Mast cells and 
inflammatory cytokine trafficking (Bassotti & Villanacci, 2012; Bassotti et al., 2014; De 
Winter, van den Wijngaard, & de Jonge, 2012; Ohama, Hori, & Ozaki, 2007). 
Furthermore, enteric glia cells have now been shown to not only act as neuronal support 
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cells but to contribute to GI motility. Studies by Qi R et al (Bassotti, Villanacci, Antonelli, 
Morelli, & Salerni, 2007; Qi, Yang, & Chen, 2013) showed that enteric glia cell 
morphology and numbers are affected during GI motility disorders. Enteric glia cells are 
now considered as major players in GI motility (Bassotti et al., 2007; Qi et al., 2013). 
Our studies showed that Tat directly modulates enteric neurons and glia leading to an up-
regulation of pro-inflammatory cytokines. In this aim, we sought to determine if these 
effects of Tat and its interaction with LPS on the enteric nervous system affects GI 
motility.  In this aim, we studied the effects of Tat on gastric emptying rate (by studying 
stomach stasis), caecum water content, GI transit rate (by counting the number of fecal 
pellets), colonic transit rate and motility patterns of the mouse ileum using the GIMM.  
Given that Tat and LPS significantly affected neurons and glia and increased pro-
inflammatory cytokine levels, we hypothesized that GI motility will be significantly 
disturbed in mice expressing the Tat gene. 
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Results 
Tat increased GI motility 
To determine the effects of Tat on GI motility, upper GI tract motility was measured by 
calculating % charcoal transit/ total ileum length as described in the methods section. The 
distance travelled in Tat+ mice was modestly but significantly greater than control Tat- 
mice (p < 0.05) (Figure 25A). These initial experiments were conducted on mice that were 
continuously fed with DOX for 2 weeks to induce the expression of the tat transgene. 
Continuous treatment with DOX reduces the number of certain types of gut microbiota. So, 
we decided to replace the DOX diet with regular CHOW in order to avoid the interference 
of the DOX diet used to induce Tat expression on GI effects and to allow for 
recolonization of the gut by gut bacteria. In the next set of experiments we used a treatment 
paradigm in which, age-matched mice were fed with DOX chow for 1 week after which 
the DOX chow was substituted for a regular chow for 3 weeks. PCR experiments showed 
that the tat gene expression was maintained after 3 weeks without DOX in Tat+ ileum and 
absent in Tat- ileum (Figure 25B). There was no significant difference in the rate of 
stomach stasis in Tat+ mice compared to Tat- mice (Figure 25C). On the other hand, Tat+ 
mice contained more fluids in their caecum than Tat- mice, which had significantly lower 
caecum water content than Tat+ mice (Figure 25D). Analysis of the GI transit rate showed 
that Tat+ mice had a faster stool output rates compared to Tat- mice (Figure 25E).  
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Figure 25. Tat increased GI motility in Tat transgenic mice.  Tat+ mice showed higher 
upper GI transit rates compared to Tat- (A).  GI transit was measured as distance travelled 
by charcoal meal. Q-PCR showing expression of Tat following 1 week DOX treatment 
followed by three weeks regular chow diet. Tat was expressed in Tat+ and absent in Tat- 
mouse ileum after three weeks without DOX (B). Gastric emptying showing no significant 
difference in stomach stasis rates between Tat+ and Tat- mice (C). caecum water content 
significantly higher in Tat+ mice than in Tat- (D). Number of stool pellets expelled was 
significantly higher in Tat+ than Tat- (E). Significance was determined via student T-test. 
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Tat+ mice had higher rates of bacterial translocation than Tat- mice. 
To determine the role of Tat and increased pro-inflammatory cytokines on gut bacterial 
translocation, we assessed the rate of bacterial translocation to mesenteric lymph nodes 
(MLN), liver and spleen. After replacing the DOX diet with regular CHOW for 1 week, 
MLN, spleen and liver of both Tat+ and Tat- mice were cultured in aerobic conditions. We 
found that the MLN, spleen and liver of Tat+ mice had significantly higher bacterial 
colony forming units (CFU)/ mL of tissue homogenates than Tat – controls (Figure 26A, 
B&C). This data shows significantly higher rates of gut bacterial translocation in Tat+ 
mice than in Tat- mice. The highest rate of translocation was to the MLN. 
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Figure 26. Bacterial translocation. Quantification of bacterial colony forming units in 
(A) MLN, (B) Spleen, (C) Liver. Data plotted as Mean ± SEM. n=3. P<0.05 (students t 
test) *Vs Tat- 
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Tat+ mice were more sensitive to LPS mediated decrease in colonic motility than Tat- 
mice 
To further examine the functional aspects of the Tat/LPS interaction on GI motility, a 
video based gastrointestinal motility monitor (GIMM) system was used to generate 
spatiotemporal maps of the ileum and assess pellet expulsion in the colon. 
Figure 27A and B show a typical recording of the spatiotemporal map of ileal contractions 
from Tat- and Tat+ mice. The spatiotemporal maps revealed significant high frequency, 
low amplitude contractions throughout the ileum. These contractions occurred across the 
entire length of the ileum at varying frequencies. The contractions, which we denoted as 
“ripples”, are similar to the findings in gastrointestinal tissue from embryonic rats reported 
by Roberts et al (Roberts et al., 2010).   
To study the effects of Tat and LPS on these motor patterns in the ileum, the diameter of 
the ileum was read every 0.22 mm along the entire length of the ileum, every 0.067 sec. 
The frequency was measured over a 5 min period and divided between proximal and distal 
segments of the ileum. The proximal ileum of Tat+ mice demonstrated a greater frequency 
of diameter changes than Tat- mice (Figure 27C). This difference was not observed in the 
more distal segments of the ileum. In mice treated with LPS, Tat+ mice were more 
sensitive to LPS-mediated decreases in the number of diameter changes than Tat- mice in 
the proximal ileum (Figure 27C). In contrast, in the distal ileum, there was no difference 
in the rate of LPS mediated decrease in diameter changes in Tat- and Tat+ mice (Figure 
27C).  
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We assessed the interactions between LPS and Tat on colonic propulsion. The number of 
natural colonic pellets expelled in 30 min was recorded and the data presented as percent 
colonic pellet expulsion rate. There was no difference in the number of pellets between the 
two groups when removed from the animal (Table 2).  Tat- mice expelled 24.3% of their 
natural pellets, whereas Tat+ mice expelled 92.1% of the natural pellets. LPS treated mice 
had reduced pellet expulsion rates: 13.3 % in Tat- mice and 18.8% in Tat+ mice indicative 
of increased sensitivity of LPS in the Tat+ mice (Figure 27D &E). 
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Figure 27. GI effects of Tat and LPS interaction. Representative spatiotemporal maps of 
the mouse ileum with the proximal portion zoomed in, to show contraction and relaxation 
representative of segmented motor patterns in Tat-(A) and Tat+(B). C) Quantification of 
number of diameter changes in the proximal and distal ileum. LPS was administered at a 
dose of 50 µg/mL, in drinking water for 1 week. D) Quantification colonic transit 
measured as rate of expulsion of natural pellets in 30 min. E) Representative pictures 
showing the number of pellets expelled in Tat+ and Tat- mouse colon. n=5-6. P<0.05 
(students t test) *Vs Tat- or Tat+. 
A 
B 
C 
D 
E 
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Table 3. Colon length and number of pellets immediately after dissection: There was no 
significant difference in colon length or number of fecal pellets in Tat+ and Tat- mice. 
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Discussion of aim 3 
Both increases in neuronal excitability and pro-inflammatory cytokines have been reported 
to correlate with increased GI motility and to contribute to the diarrhea observed in many 
GI disorders. GI dysmotilities and diarrhea are persistent problems in the cART era 
(Mathur, Verma, Makwana, & Sinha, 2013; Mitra, Hernandez, Hernandez, & Siddiq, 2001). 
Upper GI transit was slightly but significantly higher in Tat+ mice maintained on DOX for 
two weeks. Since microbiota may affect GI motility, we examined gastric stasis, caecum 
water content and fecal water content after recolonization of colonic bacteria. Under these 
conditions, gastrointestinal transit was markedly enhanced. Further studies are required to 
determine if the increase in caecum water content was due to increased secretion or reduced 
reabsorption.  
The enteric nervous system regulates various motor patterns in the gut. Two main motor 
patterns are observed in the small intestine. These include peristalsis, which is responsible 
for propelling the bolus and segmented contractions that mixes the bolus allowing time for 
digestion and absorption of nutrients (Huizinga et al., 2014). These motility patterns have 
been shown to be controlled by interaction of the ENS and interstitial cells of Cajal (ICCs) 
(Huizinga et al., 2011; Huizinga et al., 2014). Gut inflammation has been shown to cause 
remodeling of the enteric nervous system in various GI diseases (Mawe, Strong, & 
Sharkey, 2009). We hypothesized that the increase in cytokine release observed will 
remodel cells of the enteric nervous system and thus affect GI motility patterns. Here, we 
studied the effects of Tat and LPS on segmented motor activities in the mouse ileum of Tat 
transgenic mice. We found that Tat+ mice were more sensitive to LPS mediated decreases 
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in the number of changes in ileum diameter. The proximal ileum was the most sensitive. 
Colonic transit rates were also significantly increased in the Tat+ mice. In the presence of 
LPS, the colonic transit time in Tat + mice was significantly reduced compared to the Tat – 
mice.   
These findings suggest that Tat and its interaction with LPS directly modulate enteric 
neurons and glia, leading to a significant up-regulation of inflammatory cytokines. This 
up-regulation of inflammatory cytokines together with Tat’s direct effect on these cells 
significantly modulate GI transit rate and GI motility patterns. Further studies are required 
to tease apart the role played by each of these players in the GI dysmotility phenotype 
observed in Tat+ mice. 
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Chapter VI 
Conclusions and perspectives 
Taken together, these studies have analyzed the effects of Tat at a single neuronal level and 
showed that Tat increases enteric neuronal excitability by modulating sodium channels. 
The increase in neuronal excitability together with an increase in pro-inflammatory 
cytokine release could account for the increase in GI motility observed in Tat+ mice. These 
findings correlate with an increase in GI motility and diarrhea observed in HIV infected 
individuals and explain a possible mechanism by which this may be occurring. The brain-
gut axis has also gained recent interest with the findings that many CNS diseases may have 
an ENS component. For example, GI disturbances and the presence of Lewy bodies in 
enteric neurons of Parkinson disease patients occur decades prior to advent of motor 
symptoms (Pan-Montojo et al., 2012). The ileum, in particular, is one of the earliest sites 
of infection (Levesque et al., 2009) and displays a higher proportion of HIV-infected cells 
than other regions of the GI tract (S. Yukl & Wong, 2008).  
The adult human gut contains about 100 trillion microorganisms that constitute the gut 
microbiome (Ley, Peterson, & Gordon, 2006). These organisms contribute to gut function 
by maintaining the gut epithelial wall integrity, fighting against other pathogenic 
microorganisms, providing metabolic support for the host and mediating inflammatory 
responses. During HIV infections, there is dysbiosis – down regulation of gut bacteria that 
are linked to anti-inflammatory effects (Bacteroides) and up-regulation of those that have 
been shown to be linked to inflammatory states in the GI (Proteobacteria) (Lozupone et al., 
2013; Nwosu, Avershina, Wilson, & Rudi, 2014; Vujkovic-Cvijin et al., 2013). This 
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dysbiosis is also accompanied by increased bacterial translocation. Bacterial and viral 
proteins pass through the gut wall and can translocate to the general circulation. In 
addition, other cells of the gastrointestinal tract that were not normally exposed to HIV, 
viral proteins, bacteria and bacterial proteins can now be exposed to these. In this study, we 
showed that the HIV protein, Tat, enhanced bacterial translocation to the mesenteric lymph 
node, spleen and liver. We also showed that Tat and LPS significantly induced the release 
of pro-inflammatory cytokines in enteric neurons and glia cells.  This significant 
upregulation of pro-inflammatory cytokines was accompanied by profound disruption of 
GI motility. GI transit rate was significantly faster in mice that expressed the tat transgene 
than in age and weight-matched controls. Tat modulated the ilea and colon of Tat 
transgenic mice making them more sensitive to LPS’s effect. Further studies are needed to 
shed more light on the mechanisms underlying the effects of Tat and LPS on GI motility. 
Nevertheless, these studies have elucidated a mechanism for the interaction of Tat and LPS 
on the enteric nervous system leading to the upregulation of pro-inflammatory cytokine 
release. This mechanism involves the TLR4 receptor and appears to occur via a MyD88-
dependent pathway. Further structural and mechanistic studies will enable us to determine 
if the binding of Tat to the TLR4/MD2 complex modulates the receptor making it more 
sensitive to LPS-mediated effects on pro-inflammatory cytokine.  
Increase in pro-inflammatory cytokines has been shown to further affect gut epithelial 
membrane integrity. This may lead to further enhancement of bacterial translocation. Since 
patients who are on cART treatment have reduced rates of viral replication, it is believed 
that the ongoing inflammation and immune activation may be primarily due to bacterial 
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translocation. This persistent inflammation in these patients may lead to further 
complications such as atherosclerosis, neurodegenerative disorders and other end organ 
complications. 
These studies highlight the role of HIV viral and bacterial proteins in HIV pathogenesis in 
the gastrointestinal tract and also demonstrate a critical role of the enteric nervous system 
in HIV pathogenesis.  
  
  
91 
 
 
 
 
 
 
 
 
 
 
 
 
Literature Cited 
 
  
  
92 
References 
Abecasis, A. B., Wensing, A. M., Paraskevis, D., Vercauteren, J., Theys, K., Van de Vijver, D. A., 
. . . Vandamme, A. M. (2013). HIV-1 subtype distribution and its demographic determinants 
in newly diagnosed patients in europe suggest highly compartmentalized epidemics. 
Retrovirology, 10, 7-4690-10-7. doi:10.1186/1742-4690-10-7 [doi] 
Akbarali, H. I., & Giles, W. R. (1993). Ca2+ and ca(2+)-activated cl- currents in rabbit 
oesophageal smooth muscle. The Journal of Physiology, 460, 117-133.  
Anderson, V. M., Greco, M. A., Recalde, A. L., Chandwani, S., Church, J. A., & Krasinski, K. 
(1990). Intestinal cytomegalovirus ganglioneuronitis in children with human 
immunodeficiency virus infection. Pediatric Pathology / Affiliated with the International 
Paediatric Pathology Association, 10(1-2), 167-174.  
Anitha, M., Vijay-Kumar, M., Sitaraman, S. V., Gewirtz, A. T., & Srinivasan, S. (2012). Gut 
microbial products regulate murine gastrointestinal motility via toll-like receptor 4 signaling. 
Gastroenterology, 143(4), 1006-16.e4. doi:10.1053/j.gastro.2012.06.034 [doi] 
Asakawa, A., Inui, A., Kaga, T., Katsuura, G., Fujimiya, M., Fujino, M. A., & Kasuga, M. (2003). 
Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut, 52(7), 
947-952.  
Barbara, G., Stanghellini, V., Cremon, C., De Giorgio, R., & Corinaldesi, R. (2008). What is the 
effect of inflammation on intestinal function? Inflammatory Bowel Diseases, 14 Suppl 2, 
S140-4. doi:10.1002/ibd.20701; 10.1002/ibd.20701 
  
93 
Barnes, K. J., Beckett, E. A., Brookes, S. J., Sia, T. C., & Spencer, N. J. (2014). Control of intrinsic 
pacemaker frequency and velocity of colonic migrating motor complexes in mouse. Frontiers 
in Neuroscience, 8, 96. doi:10.3389/fnins.2014.00096 [doi] 
Bassotti, G., Antonelli, E., Villanacci, V., Salemme, M., Coppola, M., & Annese, V. (2014). 
Gastrointestinal motility disorders in inflammatory bowel diseases. World Journal of 
Gastroenterology : WJG, 20(1), 37-44. doi:10.3748/wjg.v20.i1.37 [doi] 
Bassotti, G., & Villanacci, V. (2012). Mast cells in intestinal motility disorders: Please also look 
beyond IBS... Digestive Diseases and Sciences, 57(9), 2475-6; author reply 2476. 
doi:10.1007/s10620-012-2303-4; 10.1007/s10620-012-2303-4 
Bassotti, G., Villanacci, V., Antonelli, E., Morelli, A., & Salerni, B. (2007). Enteric glial cells: 
New players in gastrointestinal motility? Laboratory Investigation; a Journal of Technical 
Methods and Pathology, 87(7), 628-632. doi:3700564 [pii] 
Batman, P. A., Miller, A. R., Sedgwick, P. M., & Griffin, G. E. (1991a). Autonomic denervation in 
jejunal mucosa of homosexual men infected with HIV. AIDS (London, England), 5(10), 1247-
1252.  
Batman, P. A., Miller, A. R., Sedgwick, P. M., & Griffin, G. E. (1991b). Autonomic denervation in 
jejunal mucosa of homosexual men infected with HIV. AIDS (London, England), 5(10), 1247-
1252.  
Ben Haij, N., Leghmari, K., Planes, R., Thieblemont, N., & Bahraoui, E. (2013). HIV-1 tat protein 
binds to TLR4-MD2 and signals to induce TNF-alpha and IL-10. Retrovirology, 10, 123-
4690-10-123. doi:10.1186/1742-4690-10-123 [doi] 
  
94 
Bhaijee, F., Subramony, C., Tang, S. J., & Pepper, D. J. (2011). Human immunodeficiency virus-
associated gastrointestinal disease: Common endoscopic biopsy diagnoses. Pathology 
Research International, 2011, 247923. doi:10.4061/2011/247923; 10.4061/2011/247923 
Brailoiu, G. C., Brailoiu, E., Chang, J. K., & Dun, N. J. (2008). Excitatory effects of human 
immunodeficiency virus 1 tat on cultured rat cerebral cortical neurons. Neuroscience, 151(3), 
701-710. doi:10.1016/j.neuroscience.2007.11.031; 10.1016/j.neuroscience.2007.11.031 
Brenchley, J. M. (2013). Mucosal immunity in human and simian immunodeficiency lentivirus 
infections. Mucosal Immunology, 6(4), 657-665. doi:10.1038/mi.2013.15; 
10.1038/mi.2013.15 
Brenchley, J. M., & Douek, D. C. (2008). HIV infection and the gastrointestinal immune system. 
Mucosal Immunology, 1(1), 23-30. doi:10.1038/mi.2007.1 [doi] 
Brenchley, J. M., Paiardini, M., Knox, K. S., Asher, A. I., Cervasi, B., Asher, T. E., . . . Douek, D. 
C. (2008). Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral 
infections. Blood, 112(7), 2826-2835. doi:10.1182/blood-2008-05-159301; 10.1182/blood-
2008-05-159301 
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., . . . 
Douek, D. C. (2004). CD4+ T cell depletion during all stages of HIV disease occurs 
predominantly in the gastrointestinal tract. The Journal of Experimental Medicine, 200(6), 
749-759. doi:10.1084/jem.20040874 
  
95 
Brierley, S. M., & Linden, D. R. (2014). Neuroplasticity and dysfunction after gastrointestinal 
inflammation. Nature Reviews.Gastroenterology & Hepatology, 11(10), 611-627. 
doi:10.1038/nrgastro.2014.103 [doi] 
Bruce-Keller, A. J., Turchan-Cholewo, J., Smart, E. J., Geurin, T., Chauhan, A., Reid, R., . . . 
Hauser, K. F. (2008). Morphine causes rapid increases in glial activation and neuronal injury 
in the striatum of inducible HIV-1 tat transgenic mice. Glia, 56(13), 1414-1427. 
doi:10.1002/glia.20708; 10.1002/glia.20708 
Buccigrossi, V., Laudiero, G., Nicastro, E., Miele, E., Esposito, F., & Guarino, A. (2011). The 
HIV-1 transactivator factor (tat) induces enterocyte apoptosis through a redox-mediated 
mechanism. PloS One, 6(12), e29436. doi:10.1371/journal.pone.0029436; 
10.1371/journal.pone.0029436 
Buonaguro, L., Tornesello, M. L., & Buonaguro, F. M. (2007). Human immunodeficiency virus 
type 1 subtype distribution in the worldwide epidemic: Pathogenetic and therapeutic 
implications. Journal of Virology, 81(19), 10209-10219. doi:JVI.00872-07 [pii] 
Cabarrocas, J., Savidge, T. C., & Liblau, R. S. (2003). Role of enteric glial cells in inflammatory 
bowel disease. Glia, 41(1), 81-93. doi:10.1002/glia.10169 [doi] 
Canani, R. B., Cirillo, P., Mallardo, G., Buccigrossi, V., Secondo, A., Annunziato, L., . . . Guarino, 
A. (2003). Effects of HIV-1 tat protein on ion secretion and on cell proliferation in human 
intestinal epithelial cells. Gastroenterology, 124(2), 368-376. doi:10.1053/gast.2003.50056 
  
96 
Canani, R. B., De Marco, G., Passariello, A., Buccigrossi, V., Ruotolo, S., Bracale, I., . . . Guarino, 
A. (2006). Inhibitory effect of HIV-1 tat protein on the sodium-D-glucose symporter of 
human intestinal epithelial cells. AIDS (London, England), 20(1), 5-10.  
Chandra, T., Maier, W., Konig, H. G., Hirzel, K., Kogel, D., Schuler, T., . . . Laube, B. (2005). 
Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein 
tat with N-methyl-d-aspartate receptor subunits. Neuroscience, 134(1), 145-153. 
doi:10.1016/j.neuroscience.2005.02.049 
Chang, H. C., Samaniego, F., Nair, B. C., Buonaguro, L., & Ensoli, B. (1997a). HIV-1 tat protein 
exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated 
heparan sulfate proteoglycans through its basic region. AIDS (London, England), 11(12), 
1421-1431.  
Chang, H. C., Samaniego, F., Nair, B. C., Buonaguro, L., & Ensoli, B. (1997b). HIV-1 tat protein 
exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated 
heparan sulfate proteoglycans through its basic region. AIDS (London, England), 11(12), 
1421-1431.  
Chaudhury, A., Shariff, A., Srinivas, M., & Sabherwal, U. (2004). Changes in nitrergic innervation 
of defunctionalized rat colon after diversion colostomy. Neurogastroenterology and Motility : 
The Official Journal of the European Gastrointestinal Motility Society, 16(4), 475-487. 
doi:10.1111/j.1365-2982.2004.00565.x [doi] 
  
97 
Cheadle, G. A., Costantini, T. W., Lopez, N., Bansal, V., Eliceiri, B. P., & Coimbra, R. (2013). 
Enteric glia cells attenuate cytomix-induced intestinal epithelial barrier breakdown. PloS One, 
8(7), e69042. doi:10.1371/journal.pone.0069042 [doi] 
Chiu, I. M., Heesters, B. A., Ghasemlou, N., Von Hehn, C. A., Zhao, F., Tran, J., . . . Woolf, C. J. 
(2013). Bacteria activate sensory neurons that modulate pain and inflammation. Nature, 
501(7465), 52-57. doi:10.1038/nature12479; 10.1038/nature12479 
Ciesielczyk, K., & Thor, P. J. (2013). Neural control disturbances of the gastrointestinal tract and 
visceral pain in inflammatory bowel diseases. [Zaburzenia kontroli nerwowej przewodu 
pokarmowego i bol trzewny w nieswoistych chorobach zapalnych jelits] Postepy Higieny i 
Medycyny Doswiadczalnej (Online), 67, 304-314.  
Coquenlorge, S., Duchalais, E., Chevalier, J., Cossais, F., Rolli-Derkinderen, M., & Neunlist, M. 
(2014). Modulation of lipopolysaccharide-induced neuronal response by activation of the 
enteric nervous system. Journal of Neuroinflammation, 11(1), 202. doi:s12974-014-0202-7 
[pii] 
Cornblath, D. R., & Hoke, A. (2006). Recent advances in HIV neuropathy. Current Opinion in 
Neurology, 19(5), 446-450. doi:10.1097/01.wco.0000245366.59446.57 [doi] 
Cummins, T. R., Rush, A. M., Estacion, M., Dib-Hajj, S. D., & Waxman, S. G. (2009). Voltage-
clamp and current-clamp recordings from mammalian DRG neurons. Nature Protocols, 4(8), 
1103-1112. doi:10.1038/nprot.2009.91 [doi] 
  
98 
De Winter, B. Y., van den Wijngaard, R. M., & de Jonge, W. J. (2012). Intestinal mast cells in gut 
inflammation and motility disturbances. Biochimica Et Biophysica Acta, 1822(1), 66-73. 
doi:10.1016/j.bbadis.2011.03.016 [doi] 
Debaisieux, S., Lachambre, S., Gross, A., Mettling, C., Besteiro, S., Yezid, H., . . . Beaumelle, B. 
(2015). HIV-1 tat inhibits phagocytosis by preventing the recruitment of Cdc42 to the 
phagocytic cup. Nature Communications, 6, 6211. doi:10.1038/ncomms7211 [doi] 
Ekberg, J., & Adams, D. J. (2006). Neuronal voltage-gated sodium channel subtypes: Key roles in 
inflammatory and neuropathic pain. The International Journal of Biochemistry & Cell 
Biology, 38(12), 2005-2010. doi:10.1016/j.biocel.2006.06.008 
El-Hage, N., Bruce-Keller, A. J., Knapp, P. E., & Hauser, K. F. (2008). CCL5/RANTES gene 
deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and 
activation in HIV-1 tat-exposed mice. Journal of Neuroimmune Pharmacology : The Official 
Journal of the Society on NeuroImmune Pharmacology, 3(4), 275-285. doi:10.1007/s11481-
008-9127-1; 10.1007/s11481-008-9127-1 
El-Hage, N., Gurwell, J. A., Singh, I. N., Knapp, P. E., Nath, A., & Hauser, K. F. (2005). 
Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by 
astrocytes treated with opiates and HIV-1 tat. Glia, 50(2), 91-106. doi:10.1002/glia.20148 
Ellis, R., Langford, D., & Masliah, E. (2007). HIV and antiretroviral therapy in the brain: Neuronal 
injury and repair. Nature Reviews.Neuroscience, 8(1), 33-44. doi:10.1038/nrn2040 
Estes, J. D., Harris, L. D., Klatt, N. R., Tabb, B., Pittaluga, S., Paiardini, M., . . . Brenchley, J. M. 
(2010). Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic 
  
99 
simian immunodeficiency virus infections. PLoS Pathogens, 6(8), e1001052. 
doi:10.1371/journal.ppat.1001052; 10.1371/journal.ppat.1001052 
Fernandes, S. M., Pires, A. R., Ferreira, C., Tendeiro, R., Correia, L., Paulo, S. E., . . . Sousa, A. E. 
(2014). Gut disruption in HIV-2 infection despite reduced viremia. AIDS (London, England), 
28(2), 290-292. doi:10.1097/QAD.0000000000000114 [doi] 
Fitting, S., Ngwainmbi, J., Kang, M., Khan, F. A., Stevens, D. L., Dewey, W. L., . . . Akbarali, H. 
I. (2015). Sensitization of enteric neurons to morphine by HIV-1 tat protein. 
Neurogastroenterology and Motility : The Official Journal of the European Gastrointestinal 
Motility Society, doi:10.1111/nmo.12514 [doi] 
Fried, R. L., Brandt, L. J., Kauvar, D., & Simon, D. (1994). Esophageal motility in AIDS patients 
with symptomatic opportunistic infections of the esophagus. The American Journal of 
Gastroenterology, 89(11), 2003-2005.  
Furness, J. B. (2012). The enteric nervous system and neurogastroenterology. Nature 
Reviews.Gastroenterology & Hepatology, 9(5), 286-294. doi:10.1038/nrgastro.2012.32; 
10.1038/nrgastro.2012.32 
Goldstein, G. (1996). HIV-1 tat protein as a potential AIDS vaccine. Nature Medicine, 2(9), 960-
964.  
Gonzalez-Scarano, F., & Martin-Garcia, J. (2005). The neuropathogenesis of AIDS. Nature 
Reviews.Immunology, 5(1), 69-81. doi:10.1038/nri1527 
  
100 
Grenham, S., Clarke, G., Cryan, J. F., & Dinan, T. G. (2011). Brain-gut-microbe communication in 
health and disease. Frontiers in Physiology, 2, 94. doi:10.3389/fphys.2011.00094; 
10.3389/fphys.2011.00094 
Griffin, G. E., Miller, A., Batman, P., Forster, S. M., Pinching, A. J., Harris, J. R., & Mathan, M. 
M. (1988). Damage to jejunal intrinsic autonomic nerves in HIV infection. AIDS (London, 
England), 2(5), 379-382.  
Gudes, S., Barkai, O., Caspi, Y., Katz, B., Lev, S., & Binshtok, A. M. (2015). The role of slow and 
persistent TTX-resistant sodium currents in acute tumor necrosis factor-alpha-mediated 
increase in nociceptors excitability. Journal of Neurophysiology, 113(2), 601-619. 
doi:10.1152/jn.00652.2014 [doi] 
Guijarro-Munoz, I., Compte, M., Alvarez-Cienfuegos, A., Alvarez-Vallina, L., & Sanz, L. (2014). 
Lipopolysaccharide activates toll-like receptor 4 (TLR4)-mediated NF-kappaB signaling 
pathway and proinflammatory response in human pericytes. The Journal of Biological 
Chemistry, 289(4), 2457-2468. doi:10.1074/jbc.M113.521161 [doi] 
Hagar, J. A., Powell, D. A., Aachoui, Y., Ernst, R. K., & Miao, E. A. (2013). Cytoplasmic LPS 
activates caspase-11: Implications in TLR4-independent endotoxic shock. Science (New York, 
N.Y.), 341(6151), 1250-1253. doi:10.1126/science.1240988 [doi] 
Handley, S. A., Thackray, L. B., Zhao, G., Presti, R., Miller, A. D., Droit, L., . . . Virgin, H. W. 
(2012). Pathogenic simian immunodeficiency virus infection is associated with expansion of 
the enteric virome. Cell, 151(2), 253-266. doi:10.1016/j.cell.2012.09.024; 
10.1016/j.cell.2012.09.024 
  
101 
Hockley, J. R., Boundouki, G., Cibert-Goton, V., McGuire, C., Yip, P. K., Chan, C., . . . Bulmer, 
D. C. (2014). Multiple roles for NaV1.9 in the activation of visceral afferents by noxious 
inflammatory, mechanical, and human disease-derived stimuli. Pain, 155(10), 1962-1975. 
doi:10.1016/j.pain.2014.06.015 [doi] 
Huizinga, J. D., Chen, J. H., Zhu, Y. F., Pawelka, A., McGinn, R. J., Bardakjian, B. L., . . . Chen, 
D. (2014). The origin of segmentation motor activity in the intestine. Nature Communications, 
5, 3326. doi:10.1038/ncomms4326 [doi] 
Huizinga, J. D., Martz, S., Gil, V., Wang, X. Y., Jimenez, M., & Parsons, S. (2011). Two 
independent networks of interstitial cells of cajal work cooperatively with the enteric nervous 
system to create colonic motor patterns. Frontiers in Neuroscience, 5, 93. 
doi:10.3389/fnins.2011.00093; 10.3389/fnins.2011.00093 
Ipp, H., Zemlin, A. E., Erasmus, R. T., & Glashoff, R. H. (2014). Role of inflammation in HIV-1 
disease progression and prognosis. Critical Reviews in Clinical Laboratory Sciences, 51(2), 
98-111. doi:10.3109/10408363.2013.865702 [doi] 
Johnson, T. P., Patel, K., Johnson, K. R., Maric, D., Calabresi, P. A., Hasbun, R., & Nath, A. 
(2013a). Induction of IL-17 and nonclassical T-cell activation by HIV-tat protein. 
Proceedings of the National Academy of Sciences of the United States of America, 110(33), 
13588-13593. doi:10.1073/pnas.1308673110 [doi] 
Johnson, T. P., Patel, K., Johnson, K. R., Maric, D., Calabresi, P. A., Hasbun, R., & Nath, A. 
(2013b). Induction of IL-17 and nonclassical T-cell activation by HIV-tat protein. 
  
102 
Proceedings of the National Academy of Sciences of the United States of America, 110(33), 
13588-13593. doi:10.1073/pnas.1308673110 [doi] 
Johri, M. K., Mishra, R., Chhatbar, C., Unni, S. K., & Singh, S. K. (2011). Tits and bits of HIV tat 
protein. Expert Opinion on Biological Therapy, 11(3), 269-283. 
doi:10.1517/14712598.2011.546339 [doi] 
Jung, G. Y., Lee, J. Y., Rhim, H., Oh, T. H., & Yune, T. Y. (2013). An increase in voltage-gated 
sodium channel current elicits microglial activation followed inflammatory responses in vitro 
and in vivo after spinal cord injury. Glia, 61(11), 1807-1821. doi:10.1002/glia.22559 [doi] 
Kamm, K., Hoppe, S., Breves, G., Schroder, B., & Schemann, M. (2004). Effects of the probiotic 
yeast saccharomyces boulardii on the neurochemistry of myenteric neurones in pig jejunum. 
Neurogastroenterology and Motility : The Official Journal of the European Gastrointestinal 
Motility Society, 16(1), 53-60. doi:458 [pii] 
Karn, J. (1999). Tackling tat. Journal of Molecular Biology, 293(2), 235-254. 
doi:10.1006/jmbi.1999.3060 [doi] 
Kaul, M., Garden, G. A., & Lipton, S. A. (2001). Pathways to neuronal injury and apoptosis in 
HIV-associated dementia. Nature, 410(6831), 988-994. doi:10.1038/35073667 
Kedzierska, K., & Crowe, S. M. (2001). Cytokines and HIV-1: Interactions and clinical 
implications. Antiviral Chemistry & Chemotherapy, 12(3), 133-150.  
  
103 
Kilareski, E. M., Shah, S., Nonnemacher, M. R., & Wigdahl, B. (2009). Regulation of HIV-1 
transcription in cells of the monocyte-macrophage lineage. Retrovirology, 6, 118-4690-6-118. 
doi:10.1186/1742-4690-6-118; 10.1186/1742-4690-6-118 
Klase, Z., Ortiz, A., Deleage, C., Mudd, J. C., Quinones, M., Schwartzman, E., . . . Brenchley, J. 
M. (2015). Dysbiotic bacteria translocate in progressive SIV infection. Mucosal Immunology, 
doi:10.1038/mi.2014.128 [doi] 
Klatt, N. R., Funderburg, N. T., & Brenchley, J. M. (2013). Microbial translocation, immune 
activation, and HIV disease. Trends in Microbiology, 21(1), 6-13. 
doi:10.1016/j.tim.2012.09.001 [doi] 
Konturek, J. W., Fischer, H., van der Voort, I. R., & Domschke, W. (1997). Disturbed gastric 
motor activity in patients with human immunodeficiency virus infection. Scandinavian 
Journal of Gastroenterology, 32(3), 221-225.  
Kotler, D. P. (2005). HIV infection and the gastrointestinal tract. AIDS (London, England), 19(2), 
107-117.  
Kotler, D. P., Reka, S., & Clayton, F. (1993). Intestinal mucosal inflammation associated with 
human immunodeficiency virus infection. Digestive Diseases and Sciences, 38(6), 1119-1127.  
Kristoff, J., Haret-Richter, G., Ma, D., Ribeiro, R. M., Xu, C., Cornell, E., . . . Pandrea, I. (2014). 
Early microbial translocation blockade reduces SIV-mediated inflammation and viral 
replication. The Journal of Clinical Investigation, 124(6), 2802-2806. doi:10.1172/JCI75090 
[doi] 
  
104 
Lackner, A. A., Mohan, M., & Veazey, R. S. (2009). The gastrointestinal tract and AIDS 
pathogenesis. Gastroenterology, 136(6), 1965-1978.  
Lehmann, H. C., Chen, W., Borzan, J., Mankowski, J. L., & Hoke, A. (2011). Mitochondrial 
dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy. 
Annals of Neurology, 69(1), 100-110. doi:10.1002/ana.22150 [doi] 
Levesque, M. C., Moody, M. A., Hwang, K. K., Marshall, D. J., Whitesides, J. F., Amos, J. D., . . . 
Haynes, B. F. (2009). Polyclonal B cell differentiation and loss of gastrointestinal tract 
germinal centers in the earliest stages of HIV-1 infection. PLoS Medicine, 6(7), e1000107. 
doi:10.1371/journal.pmed.1000107; 10.1371/journal.pmed.1000107 
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006). Ecological and evolutionary forces shaping 
microbial diversity in the human intestine. Cell, 124(4), 837-848. doi:S0092-8674(06)00192-9 
[pii] 
Lim, S. G., Condez, A., Lee, C. A., Johnson, M. A., Elia, C., & Poulter, L. W. (1993). Loss of 
mucosal CD4 lymphocytes is an early feature of HIV infection. Clinical and Experimental 
Immunology, 92(3), 448-454.  
Liu, Y., Jones, M., Hingtgen, C. M., Bu, G., Laribee, N., Tanzi, R. E., . . . He, J. J. (2000). Uptake 
of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the 
neuronal metabolic balance of the receptor ligands. Nature Medicine, 6(12), 1380-1387. 
doi:10.1038/82199 [doi] 
  
105 
Lozupone, C. A., Li, M., Campbell, T. B., Flores, S. C., Linderman, D., Gebert, M. J., . . . Palmer, 
B. E. (2013). Alterations in the gut microbiota associated with HIV-1 infection. Cell Host & 
Microbe, 14(3), 329-339. doi:10.1016/j.chom.2013.08.006 [doi] 
Lu, Y. C., Yeh, W. C., & Ohashi, P. S. (2008a). LPS/TLR4 signal transduction pathway. Cytokine, 
42(2), 145-151. doi:10.1016/j.cyto.2008.01.006 [doi] 
Lu, Y. C., Yeh, W. C., & Ohashi, P. S. (2008b). LPS/TLR4 signal transduction pathway. Cytokine, 
42(2), 145-151. doi:10.1016/j.cyto.2008.01.006 [doi] 
Ma, M., & Nath, A. (1997). Molecular determinants for cellular uptake of tat protein of human 
immunodeficiency virus type 1 in brain cells. Journal of Virology, 71(3), 2495-2499.  
Mantegazza, M., Curia, G., Biagini, G., Ragsdale, D. S., & Avoli, M. (2010). Voltage-gated 
sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet 
Neurology, 9(4), 413-424. doi:10.1016/S1474-4422(10)70059-4; 10.1016/S1474-
4422(10)70059-4 
Marchetti, G., Tincati, C., & Silvestri, G. (2013). Microbial translocation in the pathogenesis of 
HIV infection and AIDS. Clinical Microbiology Reviews, 26(1), 2-18. 
doi:10.1128/CMR.00050-12 [doi] 
Mathur, M. K., Verma, A. K., Makwana, G. E., & Sinha, M. (2013). Study of opportunistic 
intestinal parasitic infections in human immunodeficiency virus/acquired immunodeficiency 
syndrome patients. Journal of Global Infectious Diseases, 5(4), 164-167. doi:10.4103/0974-
777X.122012; 10.4103/0974-777X.122012 
  
106 
Mattapallil, J. J., Douek, D. C., Hill, B., Nishimura, Y., Martin, M., & Roederer, M. (2005). 
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV 
infection. Nature, 434(7037), 1093-1097. doi:10.1038/nature03501 
Matteoli, G. (2011). Enteric glial cells: New players in mucosal defence against bacteria? Gut, 
60(4), 429-430. doi:10.1136/gut.2010.231019 [doi] 
Mavigner, M., Cazabat, M., Dubois, M., L'Faqihi, F. E., Requena, M., Pasquier, C., . . . Delobel, P. 
(2012). Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in 
treated HIV-infected individuals. The Journal of Clinical Investigation, 122(1), 62-69. 
doi:10.1172/JCI59011; 10.1172/JCI59011 
Mawe, G. M. (2015). Colitis-induced neuroplasticity disrupts motility in the inflamed and post-
inflamed colon. The Journal of Clinical Investigation, 125(3), 949-955. doi:10.1172/JCI76306 
[doi] 
Mawe, G. M., Strong, D. S., & Sharkey, K. A. (2009). Plasticity of enteric nerve functions in the 
inflamed and postinflamed gut. Neurogastroenterology and Motility : The Official Journal of 
the European Gastrointestinal Motility Society, 21(5), 481-491. doi:10.1111/j.1365-
2982.2009.01291.x; 10.1111/j.1365-2982.2009.01291.x 
McArthur, J. C., Steiner, J., Sacktor, N., & Nath, A. (2010). Human immunodeficiency virus-
associated neurocognitive disorders: Mind the gap. Annals of Neurology, 67(6), 699-714. 
doi:10.1002/ana.22053; 10.1002/ana.22053 
McGowan, I., Elliott, J., Fuerst, M., Taing, P., Boscardin, J., Poles, M., & Anton, P. (2004). 
Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine 
  
107 
activation. Journal of Acquired Immune Deficiency Syndromes (1999), 37(2), 1228-1236. 
doi:00126334-200410010-00002 [pii] 
Mitra, A. K., Hernandez, C. D., Hernandez, C. A., & Siddiq, Z. (2001). Management of diarrhoea 
in HIV-infected patients. International Journal of STD & AIDS, 12(10), 630-639.  
Mohan, M., Kaushal, D., Aye, P. P., Alvarez, X., Veazey, R. S., & Lackner, A. A. (2012). Focused 
examination of the intestinal lamina propria yields greater molecular insight into mechanisms 
underlying SIV induced immune dysfunction. PloS One, 7(4), e34561. 
doi:10.1371/journal.pone.0034561; 10.1371/journal.pone.0034561 
Nath, A., Conant, K., Chen, P., Scott, C., & Major, E. O. (1999). Transient exposure to HIV-1 tat 
protein results in cytokine production in macrophages and astrocytes. A hit and run 
phenomenon. The Journal of Biological Chemistry, 274(24), 17098-17102.  
Nath, A., Psooy, K., Martin, C., Knudsen, B., Magnuson, D. S., Haughey, N., & Geiger, J. D. 
(1996). Identification of a human immunodeficiency virus type 1 tat epitope that is 
neuroexcitatory and neurotoxic. Journal of Virology, 70(3), 1475-1480.  
Neild, P. J., Nijran, K. S., Yazaki, E., Evans, D. F., Wingate, D. L., Jewkes, R., & Gazzard, B. G. 
(2000). Delayed gastric emptying in human immunodeficiency virus infection: Correlation 
with symptoms, autonomic function, and intestinal motility. Digestive Diseases and Sciences, 
45(8), 1491-1499.  
Neunlist, M., Rolli-Derkinderen, M., Latorre, R., Van Landeghem, L., Coron, E., Derkinderen, P., 
& De Giorgio, R. (2014). Enteric glial cells: Recent developments and future directions. 
Gastroenterology, 147(6), 1230-1237. doi:10.1053/j.gastro.2014.09.040 [doi] 
  
108 
Neunlist, M., Toumi, F., Oreschkova, T., Denis, M., Leborgne, J., Laboisse, C. L., . . . Jarry, A. 
(2003). Human ENS regulates the intestinal epithelial barrier permeability and a tight 
junction-associated protein ZO-1 via VIPergic pathways. American Journal of 
Physiology.Gastrointestinal and Liver Physiology, 285(5), G1028-36. 
doi:10.1152/ajpgi.00066.2003 
Ngwainmbi, J., De, D. D., Smith, T. H., El-Hage, N., Fitting, S., Kang, M., . . . Akbarali, H. I. 
(2014). Effects of HIV-1 tat on enteric neuropathogenesis. The Journal of Neuroscience : The 
Official Journal of the Society for Neuroscience, 34(43), 14243-14251. 
doi:10.1523/JNEUROSCI.2283-14.2014 [doi] 
Nwosu, F. C., Avershina, E., Wilson, R., & Rudi, K. (2014). Gut microbiota in HIV infection: 
Implication for disease progression and management. Gastroenterology Research and 
Practice, 2014, 803185. doi:10.1155/2014/803185 [doi] 
Ohama, T., Hori, M., & Ozaki, H. (2007). Mechanism of abnormal intestinal motility in 
inflammatory bowel disease: How smooth muscle contraction is reduced? Journal of Smooth 
Muscle Research = Nihon Heikatsukin Gakkai Kikanshi, 43(2), 43-54. 
doi:JST.JSTAGE/jsmr/43.43 [pii] 
Orandle, M. S., Veazey, R. S., & Lackner, A. A. (2007). Enteric ganglionitis in rhesus macaques 
infected with simian immunodeficiency virus. Journal of Virology, 81(12), 6265-6275. 
doi:10.1128/JVI.02671-06 
Ott, M., Dorr, A., Hetzer-Egger, C., Kaehlcke, K., Schnolzer, M., Henklein, P., . . . Verdin, E. 
(2004). Tat acetylation: A regulatory switch between early and late phases in HIV 
  
109 
transcription elongation. Novartis Foundation Symposium, 259, 182-93; discussion 193-6, 
223-5.  
Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A., . . . 
Reichmann, H. (2012). Environmental toxins trigger PD-like progression via increased alpha-
synuclein release from enteric neurons in mice. Scientific Reports, 2, 898. 
doi:10.1038/srep00898; 10.1038/srep00898 
Pardo, C. A., McArthur, J. C., & Griffin, J. W. (2001). HIV neuropathy: Insights in the pathology 
of HIV peripheral nerve disease. Journal of the Peripheral Nervous System : JPNS, 6(1), 21-
27.  
Perry, S. W., Barbieri, J., Tong, N., Polesskaya, O., Pudasaini, S., Stout, A., . . . Gelbard, H. A. 
(2010). Human immunodeficiency virus-1 tat activates calpain proteases via the ryanodine 
receptor to enhance surface dopamine transporter levels and increase transporter-specific 
uptake and vmax. The Journal of Neuroscience : The Official Journal of the Society for 
Neuroscience, 30(42), 14153-14164. doi:10.1523/JNEUROSCI.1042-10.2010; 
10.1523/JNEUROSCI.1042-10.2010 
Plantier, J. C., Leoz, M., Dickerson, J. E., De Oliveira, F., Cordonnier, F., Lemee, V., . . . Simon, F. 
(2009). A new human immunodeficiency virus derived from gorillas. Nature Medicine, 15(8), 
871-872. doi:10.1038/nm.2016 [doi] 
Plociennikowska, A., Hromada-Judycka, A., Borzecka, K., & Kwiatkowska, K. (2015a). Co-
operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cellular and 
Molecular Life Sciences : CMLS, 72(3), 557-581. doi:10.1007/s00018-014-1762-5 [doi] 
  
110 
Plociennikowska, A., Hromada-Judycka, A., Borzecka, K., & Kwiatkowska, K. (2015b). Co-
operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cellular and 
Molecular Life Sciences : CMLS, 72(3), 557-581. doi:10.1007/s00018-014-1762-5 [doi] 
Qi, R., Yang, W., & Chen, J. (2013). Role of enteric glial cells in gastric motility in diabetic rats at 
different stages. Journal of Huazhong University of Science and Technology.Medical Sciences 
= Hua Zhong Ke Ji Da Xue Xue Bao.Yi Xue Ying De Wen Ban = Huazhong Keji Daxue 
Xuebao.Yixue Yingdewen Ban, 33(4), 496-500. doi:10.1007/s11596-013-1148-1 [doi] 
Rhee, S. H. (2014). Lipopolysaccharide: Basic biochemistry, intracellular signaling, and 
physiological impacts in the gut. Intestinal Research, 12(2), 90-95. 
doi:10.5217/ir.2014.12.2.90 [doi] 
Roberts, R. R., Ellis, M., Gwynne, R. M., Bergner, A. J., Lewis, M. D., Beckett, E. A., . . . Young, 
H. M. (2010). The first intestinal motility patterns in fetal mice are not mediated by neurons or 
interstitial cells of cajal. The Journal of Physiology, 588(Pt 7), 1153-1169. 
doi:10.1113/jphysiol.2009.185421 [doi] 
Ruhl, A., Nasser, Y., & Sharkey, K. A. (2004). Enteric glia. Neurogastroenterology and Motility : 
The Official Journal of the European Gastrointestinal Motility Society, 16 Suppl 1, 44-49. 
doi:10.1111/j.1743-3150.2004.00474.x [doi] 
Sabatier, J. M., Vives, E., Mabrouk, K., Benjouad, A., Rochat, H., Duval, A., . . . Bahraoui, E. 
(1991). Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. 
Journal of Virology, 65(2), 961-967.  
  
111 
Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., . . . INSIGHT SMART 
Study Group. (2011a). Plasma levels of soluble CD14 independently predict mortality in HIV 
infection. The Journal of Infectious Diseases, 203(6), 780-790. doi:10.1093/infdis/jiq118 [doi] 
Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., . . . INSIGHT SMART 
Study Group. (2011b). Plasma levels of soluble CD14 independently predict mortality in HIV 
infection. The Journal of Infectious Diseases, 203(6), 780-790. doi:10.1093/infdis/jiq118 [doi] 
Savidge, T. C., Newman, P., Pothoulakis, C., Ruhl, A., Neunlist, M., Bourreille, A., . . . Sofroniew, 
M. V. (2007). Enteric glia regulate intestinal barrier function and inflammation via release of 
S-nitrosoglutathione. Gastroenterology, 132(4), 1344-1358. doi:10.1053/j.gastro.2007.01.051 
Shan, L., & Siliciano, R. F. (2014). Unraveling the relationship between microbial translocation 
and systemic immune activation in HIV infection. The Journal of Clinical Investigation, 
124(6), 2368-2371. doi:10.1172/JCI75799 [doi] 
Shi, J., Zhao, Y., Wang, Y., Gao, W., Ding, J., Li, P., . . . Shao, F. (2014). Inflammatory caspases 
are innate immune receptors for intracellular LPS. Nature, 514(7521), 187-192. 
doi:10.1038/nature13683 [doi] 
Simpson, D. M., & Olney, R. K. (1992). Peripheral neuropathies associated with human 
immunodeficiency virus infection. Neurologic Clinics, 10(3), 685-711.  
Singh, I. N., Goody, R. J., Dean, C., Ahmad, N. M., Lutz, S. E., Knapp, P. E., . . . Hauser, K. F. 
(2004). Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 tat 
and gp120: Differential involvement of caspase-3 and endonuclease G. Journal of 
Neurovirology, 10(3), 141-151. doi:10.1080/13550280490441103 
  
112 
Smith, T. H., Ngwainmbi, J., Grider, J. R., Dewey, W. L., & Akbarali, H. I. (2013). An in-vitro 
preparation of isolated enteric neurons and glia from the myenteric plexus of the adult mouse. 
Journal of Visualized Experiments : JoVE, (78). doi(78), 10.3791/50688. doi:10.3791/50688; 
10.3791/50688 
Smit-McBride, Z., Mattapallil, J. J., McChesney, M., Ferrick, D., & Dandekar, S. (1998). 
Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe 
CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to 
peripheral lymphocytes. Journal of Virology, 72(8), 6646-6656.  
Tonini, M., Vicini, R., Cervio, E., De Ponti, F., De Giorgio, R., Barbara, G., . . . Sternini, C. 
(2005). 5-HT7 receptors modulate peristalsis and accommodation in the guinea pig ileum. 
Gastroenterology, 129(5), 1557-1566. doi:S0016-5085(05)01581-7 [pii] 
Urbinati, C., Nicoli, S., Giacca, M., David, G., Fiorentini, S., Caruso, A., . . . Rusnati, M. (2009). 
HIV-1 tat and heparan sulfate proteoglycan interaction: A novel mechanism of lymphocyte 
adhesion and migration across the endothelium. Blood, 114(15), 3335-3342. 
doi:10.1182/blood-2009-01-198945 [doi] 
van Marle, G., Henry, S., Todoruk, T., Sullivan, A., Silva, C., Rourke, S. B., . . . Power, C. (2004). 
Human immunodeficiency virus type 1 nef protein mediates neural cell death: A neurotoxic 
role for IP-10. Virology, 329(2), 302-318. doi:S0042-6822(04)00539-2 [pii] 
Veazey, R. S., DeMaria, M., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H. L., . . . 
Lackner, A. A. (1998). Gastrointestinal tract as a major site of CD4+ T cell depletion and viral 
replication in SIV infection. Science (New York, N.Y.), 280(5362), 427-431.  
  
113 
Venkataramana, S., Lourenssen, S., Miller, K. G., & Blennerhassett, M. G. (2015). Early 
inflammatory damage to intestinal neurons occurs via inducible nitric oxide synthase. 
Neurobiology of Disease, 75, 40-52. doi:10.1016/j.nbd.2014.12.014 [doi] 
von Boyen, G., & Reinshagen, M. (2011). The enteric glia--part of the puzzle in crohn's disease? 
[Die enterische Glia--Ein Teil des Crohn Puzzles?] Zeitschrift Fur Gastroenterologie, 49(11), 
1482-1486. doi:10.1055/s-0031-1281672 [doi] 
von Boyen, G., & Steinkamp, M. (2010a). The role of enteric glia in gut inflammation. Neuron 
Glia Biology, 6(4), 231-236. doi:10.1017/S1740925X11000068; 
10.1017/S1740925X11000068 
von Boyen, G., & Steinkamp, M. (2010b). The role of enteric glia in gut inflammation. Neuron 
Glia Biology, 6(4), 231-236. doi:10.1017/S1740925X11000068 [doi] 
von Boyen, G. B., Schulte, N., Pfluger, C., Spaniol, U., Hartmann, C., & Steinkamp, M. (2011). 
Distribution of enteric glia and GDNF during gut inflammation. BMC Gastroenterology, 11, 
3-230X-11-3. doi:10.1186/1471-230X-11-3; 10.1186/1471-230X-11-3 
von Boyen, G. B., Steinkamp, M., Reinshagen, M., Schafer, K. H., Adler, G., & Kirsch, J. (2004). 
Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. 
Gut, 53(2), 222-228.  
Vujkovic-Cvijin, I., Dunham, R. M., Iwai, S., Maher, M. C., Albright, R. G., Broadhurst, M. J., . . . 
McCune, J. M. (2013). Dysbiosis of the gut microbiota is associated with HIV disease 
progression and tryptophan catabolism. Science Translational Medicine, 5(193), 193ra91. 
doi:10.1126/scitranslmed.3006438 [doi] 
  
114 
Welsh, C., Enomoto, M., Pan, J., Shifrin, Y., & Belik, J. (2013). Tetrahydrobiopterin deficiency 
induces gastroparesis in newborn mice. American Journal of Physiology.Gastrointestinal and 
Liver Physiology, 305(1), G47-57. doi:10.1152/ajpgi.00424.2012 [doi] 
Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., . . . Krammer, 
P. H. (1995). Sensitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp120. 
Nature, 375(6531), 497-500. doi:10.1038/375497a0 [doi] 
Wu, Y. (2004). HIV-1 gene expression: Lessons from provirus and non-integrated DNA. 
Retrovirology, 1, 13. doi:10.1186/1742-4690-1-13 
Xia, Y., Hu, H. Z., Liu, S., Ren, J., Zafirov, D. H., & Wood, J. D. (1999). IL-1beta and IL-6 excite 
neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric 
nervous system. The Journal of Clinical Investigation, 103(9), 1309-1316. 
doi:10.1172/JCI5823 
Xiao, H., Neuveut, C., Tiffany, H. L., Benkirane, M., Rich, E. A., Murphy, P. M., & Jeang, K. T. 
(2000). Selective CXCR4 antagonism by tat: Implications for in vivo expansion of coreceptor 
use by HIV-1. Proceedings of the National Academy of Sciences of the United States of 
America, 97(21), 11466-11471. doi:10.1073/pnas.97.21.11466 [doi] 
Yang, J., Zhao, Y., & Shao, F. (2015). Non-canonical activation of inflammatory caspases by 
cytosolic LPS in innate immunity. Current Opinion in Immunology, 32C, 78-83. doi:S0952-
7915(15)00008-4 [pii] 
  
115 
Yu, Y. B., & Li, Y. Q. (2014). Enteric glial cells and their role in the intestinal epithelial barrier. 
World Journal of Gastroenterology : WJG, 20(32), 11273-11280. 
doi:10.3748/wjg.v20.i32.11273 [doi] 
Yukl, S., & Wong, J. K. (2008). Blood and guts and HIV: Preferential HIV persistence in GI 
mucosa. The Journal of Infectious Diseases, 197(5), 640-642. doi:10.1086/527325; 
10.1086/527325 
Yukl, S. A., Shergill, A. K., Ho, T., Killian, M., Girling, V., Epling, L., . . . Wong, J. K. (2013). 
The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-
positive patients on ART: Implications for viral persistence. The Journal of Infectious 
Diseases, 208(8), 1212-1220. doi:10.1093/infdis/jit308; 10.1093/infdis/jit308 
Zalar, A. E., Olmos, M. A., Piskorz, E. L., & Magnanini, F. L. (2003). Esophageal motility 
disorders in HIV patients. Digestive Diseases and Sciences, 48(5), 962-967.  
 
  
  
116 
VITA 
	  
JOY	  NGWAINMBI	  
Education	  
Virginia	  Commonwealth	  University	  	  	  	  PhD	  of	  Pharmacology	  and	  Toxicology	  	  	  	  	  	  May	  2015	  
	   	  
University	  of	  Yaounde	  I	   Masters	  I	  of	  Clinical	  Hematology	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  July	  2009	  
	   	  
University	  of	  Yaounde	  I	   Bsc	  of	  Biomedical	  Sciences-­‐	  Clinical	  Biology	  	  	  	  July	  2008	  
Awards	  
NIH:	  Ruth	  L.	  Kirschstein	  National	  Research	  Service	  Award	  (NRSA)	  Individual	  Predoctoral	  Fellowship	  
(Parent	  F31)	  F31NS087952	  (3/14	  –	  2/16)	  PI:	  Joy	  Ngwainmbi	  	  
	  
• Initiative	  for	  maximizing	  student	  development	  scholarship	  (IMSD	  grant),	  January	  2012-­‐February	  
2014.	  
• Early	  career	  travel	  award:	  Society	  for	  Neuroimmune	  Pharmacology	  (SNIP)	  :	  March	  2014	  
• Travel	  award	  :	  American	  Society	  of	  Pharmacology	  and	  experimental	  therapeutics	  for	  Experimental	  
Biology,	  2014	  and	  2015	  
• Finalist	  :	  	  Young	  Investigator	  Award	  EB	  2014	  and	  2015	  
• Honorable	  mention:	  graduate	  student	  presentations	  at	  EB	  2014	  
	  
Manuscripts	  accepted	  for	  publication	  
• Fitting,	  S.,	  Ngwainmbi,	  J.,	  Kang,	  M.,	  Khan,	  F.	  A.,	  Stevens,	  D.	  L.,	  Dewey,	  W.	  L.,	  Knapp,	  P.	  E.,	  Hauser,	  K.	  
F.	  and	  Akbarali,	  H.	  I.	  (2015),	  Sensitization	  of	  enteric	  neurons	  to	  morphine	  by	  HIV-­‐1	  Tat	  protein.	  
Neurogastroenterology	  &	  Motility.	  doi:	  10.1111/nmo.12514	  
	  
• Ngwainmbi	  J,	   De	  DD,	   Smith	   TH,	   El-­‐Hage	  N,	   Fitting	   S,	   Kang	  M,	  Dewey	  WL,	  Hauser	   KF,	   Akbarali	   HI.J	  
Neurosci.	  2014	  Oct	  22;34(43):14243-­‐51.	  doi:	  10.1523/JNEUROSCI.2283-­‐14.2014	  
	  
• Tricia	   H.	  Smith,	  Joy	  Ngwainmbi,	  Atsushi	  Hashimoto,	  William	   L.	  Dewey,Hamid	   I.	   Akbarali	   Morphine	  
dependence	   in	   single	   enteric	   neurons	   from	   the	   mouse	   colon	   requires	   deletion	   of	  β-­‐
arrestin2	  	  Physiological	  Reports	  Sep	  2014,2(9)DOI:	  10.14814/phy2.12140	  
	  
• Smith,	   T.	   H.,	  Ngwainmbi,	   J.,	   Grider,	   J.	   R.,	   Dewey,	  W.	   L.,	   Akbarali,	   H.	   I.	   An	   In-­‐vitro	   Preparation	   of	  
Isolated	  Enteric	  Neurons	  and	  Glia	  from	  the	  Myenteric	  Plexus	  of	  the	  Adult	  Mouse.	  J.	  Vis.	  Exp.	  (78),	  
e50688,	  doi:10.3791/50688	  (2013)	  
	  
• Ngwainmbi,J.;	   Brun	   P.;	   Kang	   M.;	   Dewey,W.L.;	   Hauser,K.F.;	   Akbarali,H.I.	   HIV-­‐1	   Tat	   sensitizes	   to	  
lipopolysaccharide-­‐induced	  inflammatory	  cytokines	  via	  TLR4	  signaling	  in	  enteric	  glia	  (in	  review)	  
	  
	  
• Dipanjana	  Datta	  De,	  Sukhada	  Bhave,	  Joy	  Ngwanmbi,	  Aravind	  Gade,	  Hamid	  Akbarali,	  Willam	  Dewey	  
Morphine	  differentially	  down	  regulates	  µ-­‐opioid	  receptors	  in	  Colon	  and	  Ileum	  (in	  preparation).	  
	  
Meetings	  where	  seminar	  or	  results	  were	  presented	  	  
  
117 
Posters: 
• 	  J.	   Ngwainmbi	   and	   F.Fang.	   The	   regulation	   of	   Peroxisome	   Proliferator	   Activated	   Receptor	   Gamma	  
(PPARү)	   by	   Lysophosphatidic	   Acid	   (LPA)	   in	   Ovarian	   Cancer	   Cell	   Lines.	   Abstract	   for	   poster	  
presentation	  at	  Virginia	  academy	  of	  Science	  meeting,	  May	  26th	  2011.	  
• Joy	  Ngwainmbi,	  Tricia	  H.	  Smith,	  Kurt	  Hauser,	  William	  L.Dewey,Hamid	  I.	  Akbarali.	  Effects	  of	  HIV-­‐1	  Tat	  
protein	   on	   excitability	   of	   enteric	   neurons.	   Abstract	   for	   poster	   presentation	   at	   Experimental	  
Biology,	  Boston,	  April	  2013.	  Also	  Presented	  at	  Watts	  day	  VCU.	  
• Joy	  Ngwainmbi,	  Sylvia	  Fitting,	  Kurt	  Hauser,	  William	  L.Dewey,Hamid	   I.	  Akbarali.	  Effects	  of	  HIV-­‐1	  Tat	  
protein	   on	   enteric	   neuropathogenesis.	   Abstract	   for	   poster	   presentation	   at	   SNIP,	   New	   Orleans,	  
March	  2014.	  	  
• Joy	   Ngwainmbi,	   Sylvia	   Fitting,	   Nazira	   El	   hadge,	  William	   L.Dewey,	   	   Kurt	   Hauser,	   Hamid	   I.	   Akbarali.	  
Effects	   of	   HIV-­‐1	   Tat	   protein	   on	   enteric	   neuropathogenesis.	   Abstract	   for	   poster	   presentation	   at	  
Experimental	  Biology,	  San	  Diego,	  April	  2014.	  	  
• Joy	   Ngwainmbi,	   Sylvia	   Fitting,	   Nazira	   El	   hadge,	  William	   L.Dewey,	   	   Kurt	   Hauser,	   Hamid	   I.	   Akbarali.	  
Effects	   of	   HIV-­‐1	   Tat	   protein	   on	   enteric	   neuropathogenesis.	   Abstract	   for	   poster	   presentation	   at	  
PREP/IMSD	  Mid-­‐Atlantic,	  North	  Carolina,	  May	  2014.	  
• Ngwainmbi,J.;	  Brun	  P.;	  Kang	  M.;	  Dewey,W.L.;	  Hauser,K.F.;	  Akbarali,H.I.	  HIV-­‐1	  Tat	   sensitizes	  enteric	  
neurons	  to	  bacterial	  proteins.	  .	  Abstract	  for	  poster	  presentation	  at	  Experimental	  Biology,	  Boston,	  
March	  2015	  
Talks: 
• Effects	   of	   HIV-­‐1	   Tat	   protein	   on	   enteric	   neuropathogenesis,	   Integrative	   Systems,	   Translational	   and	  
Clinical	  Pharmacology	  Division	  Young	  Investigator	  Awards	  Platform	  Session.	  Experimental	  biology,	  
2014	  
• “Surviving	  the	  First	  Year	  of	  Grad	  School”	  PREP/IMSD	  Mid-­‐Atlantic,	  North	  Carolina,	  May	  2014	  
	  
• HIV-­‐1	   Tat	   sensitizes	   enteric	   neurons	   to	   bacterial	   proteins.	   Integrative	   Systems,	   Translational	   and	  
Clinical	  Pharmacology	  Division	  Young	  Investigator	  Awards	  Platform	  Session.	  Experimental	  Biology,	  
Boston,	  March	  2015	  
	  
	  
Leadership	  Experience	  and	  Activities	  
Pharmacology	  and	  Toxicology	  Student	  Organization	  at	  VCU	  –	  Treasurer	  	  July	  2014 - Ongoing	  
Pharmacology	  and	  Toxicology	  Student	  Organization	  at	  VCU	  -­‐	  Vice	  president	  assistant	  	  July	  2013 - July 
2014	  
	  
	  
Additional	  Information	  
Languages:	  English,	  French	  	  
 
 
